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Ventriculomegaly In Aging, Injury And Disease 
 
Rebecca Lynn Acabchuk, Ph.D. 
University of Connecticut, 2016 
 
The brain’s ventricular system provides essential functions to the central nervous system, which 
include nutrient and signal delivery, waste clearance, and homeostatic regulation of critical 
factors, and waste clearance.   It is therefore surprising that most studies neglect to consider the 
ventricular system and its ependymal lining in the etiology of neurodegenerative disease. Here, 
we investigate changes that occur to the brain in aging, injury and disease from the perspective 
of the ventricular system, its ependymal lining and surrounding periventricular structures.  Using 
a combination of post-mortem human tissue, neuro-imaging and mouse models, our studies 
highlight the importance of maintaining a healthy ependymal lining in aging, and reveal 
periventricular areas of the brain that are likely vulnerable to acceleration and rotational forces in 
mild traumatic brain injury.  Assessment of new protocols for three-dimensional visualization of 
whole tissue samples are included to promote future research of intact biological structures.  
Together, these studies emphasize the ventricular system as an important central nervous system 
feature that should be considered in the pursuit of understanding neurophysiological mechanisms 
underlying changes that occur to the brain in aging, head trauma and neurodegenerative disease.   
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This work is dedicated to 
those suffering from brain trauma,  
whether directly, or through the suffering of a loved one.   
I hope that someday there will be more treatment options available,  
and until then, I wish you and your family peace. 
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Chapter 1: Introduction* 
 
 
 
* Excerpted in part from:  
Acabchuk RL, Sun Y, Wolferz Jr R., Eastman MB., Lennington JB, Shook BA, Conover JC, 3D 
Modeling of the Lateral Ventricles and Histological Characterization of Periventricular 
Tissue in Humans and Mouse. J. Vis. Exp. (99), e52328, doi:10.3791/52328 2015. 
 
Eastman MB, Acabchuk RL, Conover JC. Neural Stem Cell Behavior in the Subventricular 
Zone as a Function of Age. Neural Stem Cells in Health and Disease. World Scientific Press. 
2015 October. 
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The Brain’s Ventricular System 
There are three main fluid systems in the brain: the ventricular system that contains and 
circulates cerebrospinal fluid (CSF), the interstitial fluid (ISF) of the parenchyma that surrounds 
neurons and glia, and the vasculature containing the blood supply. The ventricular system of the 
brain emerges during embryonic development from the neural tube, a fluid-filled cavity that 
becomes separated from the amnion.  During embryonic development, CSF pressure within the 
ventricles, along with growth factors and morphogens within the CSF, act in coordination with 
the neuroepithelium as a main driving force of brain growth and morphogenesis  (Gato, 
Desmond 2009).  The fully formed ventricular system is comprised of four inter-connected 
cavities; the lateral ventricles are the two largest cavities located in the cerebrum.  In humans, the 
anterior horns of the lateral ventricles are separated by the septum pellucidum, which is 
comprised of two thin vertical membranes that fuse together after birth.  Separation of these 
leaflets in adulthood, known as cavum septum pellucidum (CSP), is a distinguishing feature of 
Chronic Traumatic Encephalopathy (CTE)  (McKee, Stein et al. 2015). CSF flows from the 
lateral ventricles through the foramina of Monro into the third ventricle, then through 
the cerebral aqueduct into the fourth ventricle, where it then passes into the central canal of the 
spinal cord or into the cisterns of the subarachnoid space via the foramina of Luschka and 
Magendie.   CSF is then re-absorbed into venous circulation through various routes including the 
arachnoid granulations and cervical lymphatics  (Brinker, Stopa et al. 2014). The choroid plexus, 
located within the ventricles, assists in the production and filtration of CSF, forming the 
blood/CSF interface.  In addition to CSF produced from the choroid plexus, a significant portion 
of CSF may be derived from ISF passing through the ependymal cells that line the ventricular 
system  (McComb 1983).  In this thesis I will focus on changes that occur in aging and injury to 
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the ventricular system and its ependymal cells, which form the site of fluid interchange between 
ISF and CSF.  
 
Functions of the ventricular system and CSF include protection, delivery of signals and nutrients, 
fluid pressure control, removal of debris and brain homeostasis via regulation of neuroendocrine 
factors and other essential factors of the central nervous system (CNS).  Disruption of CSF flow 
can contribute to CSF retention and stagnation with reduced ability to clear metabolites, which 
can contribute to toxic accumulations within the brain  (Silverberg, Miller et al. 2010).  More 
evidence is emerging to suggest alterations in ventricular flow dynamics may be linked to 
neurodegenerative diseases through either disturbed regulation of intracranial pressure, 
accumulation of toxic metabolites or a combination of both  (Gupta, Soellinger et al. 2010).  
 
Ventriculomegaly 
Ventriculomegaly, or expansion of the lateral ventricles, is a common feature of many 
neurodegenerative diseases, including Alzheimer’s Disease (AD) and CTE  (Schott, Fox et al. 
2003, McKee, Stein et al. 2015).  Ventricle expansion in aged subjects with cognitive 
impairment is strongly correlated to increases in both cognitive decline and altered CSF 
metabolites that are known biomarkers for AD  (Apostolova, Green et al. 2012, Chou, Leporé et 
al. 2009). Ventriculomegaly is also strongly correlated to normal aging (Resnick et al., 2003). 
However, the exact cause, progression and, importantly, the impact to normal brain function are 
currently not known. New automated segmentation tools that allow for less labor-intensive 
calculations of lateral ventricle volume from magnetic resonance image (MRI) scans may 
facilitate the clinical application of ventricle volume measurements as a predictive biomarker for 
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various disease states  (Apostolova, Green et al. 2012).   
Hydrocephalus is a term often used synonymously with ventriculomegaly.  Due to the lack of a 
recognized definition of hydrocephalus, a definition was proposed by Rekate (2008) with the aim 
of achieving international consensus stating "Hydrocephalus is an active distension of the 
ventricular system of the brain resulting from inadequate passage of cerebrospinal fluid from its 
point of production within the cerebral ventricles to its point of absorption into the systemic 
circulation"  (Rekate 2008).  Thus, hydrocephalus is a pathophysiological condition thought to 
be caused by an imbalance between the production and resorption of CSF, which can take place 
at multiple sites within the ventricular system  (Jiménez, Domínguez-Pinos et al. 2014).  The 
resulting accumulation of CSF within the ventricle cavity leads to dilation of the lateral 
ventricles. In cases of adult-onset normal pressure hydrocephalus, it is likely that only a small 
increase in pressure is sufficient to generate ventricular expansion  (Jiménez, Domínguez-Pinos 
et al. 2014). Depending on the rate of intraventricular pressure (IVP) changes, symptoms of 
hydrocephalus can vary from acute headache and vomiting to the more chronic triad of 
symptoms, which are gait disturbances, urinary incontinence, and dementia. “Normal pressure 
hydrocephalus” is a controversial diagnosis, as IVP is difficult to assess, and normal pressure 
hydrocephalus is often considered a misnomer, which can impede progress in both research and 
treatment.  Case studies can be found throughout the literature of elderly patients presenting with 
deteriorating cognition and apparent normal CSF pressure that regain cognitive abilities 
following shunting  (Chu, Zeidler et al. 2006, Shukla, Vinod et al. 2010, Kiefer, Unterberg 
2012), suggesting changes in IVP, ICP and/or CSF flow are directly related to healthy brain 
functioning.  However, shunting is not an ideal intervention, as it is often associated with 
infection and other complications  (Del Bigio, Di Curzio 2016). 
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In humans, hydrocephalus is often associated with increased fluid accumulation in the 
surrounding periventricular tissue  (Kim, Jeong et al. 2015).  Periventricular fluid accumulation 
is best assessed using fluid-attenuated inversion recovery (FLAIR) MRI, which often reveals 
periventricular hyperintensities (PVH) in aged patients, indicative of edema (Fazekas et al. 1993; 
Sener 2002). Recently, symptomatic as opposed to asymptomatic hydrocephalus was found to be 
more highly associated with periventricular edema in dogs  (Laubner, Ondreka et al. 2015). 
Other terms are also used to describe PVH, including periventricular lucency and white matter 
hyperintensities (WMH). While studies have found WMH are associated with increased risk of 
stroke, dementia, and death, these studies often do not distinguish between hyperintensities 
located throughout the brain and hyperintensities specific to the periventricular region  (Debette, 
Markus 2010), which can have separate etiologies.  While it is possible that increased fluid 
accumulation underlying WMH may be due to blood-brain barrier leakage indicating small 
vessel disease, periventricular edema may also be related to disruption of the CSF/ISF barrier.  A 
recent computer-generated analysis using finite element modeling to test different trans-mantle 
pressure gradients found the degree of ventriculomegaly significantly influences the 
development of PVH, suggesting transependymal CSF absorption may be the cause of 
ventriculomegaly-related edema  (Kim, Jeong et al. 2015).  However, an intact ependymal lining 
was an underlying assumption of this model.   
Ependymal Cells 
Ependymal cells are postmitotic, cuboidal, epithelial cells that are highly polarized  (Spassky, 
Merkle et al. 2005). Ependymal cells form a monolayer lining of the ventricle cavity separating 
the CSF from the parenchyma.  The ependymal cell layer is joined together by tight junctions, 
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gap junctions and adherens junctions, and also contains the water channel protein aquaporin 4 
(AQP4).  Together, these junctions and water channels allow the ependyma to function as a 
bidirectional barrier and fluid transport system between the CSF and interstitial fluid (ISF) of the 
brain  (Kuo, Mirzadeh et al. 2006).  The majority of AQP4 channels are found along the 
basolateral membrane of the ependyma, which suggests that under normal conditions, the 
direction of bulk fluid movement flows from the parenchyma into the ventricle  (Roales-Buján, 
Páez et al. 2012). Ependymal cells contain motile cilia on their apical surface that beat in 
coordination to facilitate CSF circulation, distribute signaling molecules, maintain fluid 
homeostasis and remove debris  (Del Bigio 1995, Riquelme, Drapeau et al. 2008).  Inhibition of 
ciliary beating in adult mice has been shown to cause hydrocephalus  (Monkkonen, Hakumaki et 
al. 2007), highlighting the importance of maintaining healthy ependymal cilia for ventricular 
homeostasis. 
 
A critical area of research is aimed at elucidating the mechanisms involved in clearing the brain 
of toxic accumulations that can contribute to age-related decline and neurodegenerative disease.  
In both aging and neurodegenerative diseases such as AD and CTE, there is a decrease in the 
brain’s ability to eliminate toxins, placing the barriers of the brain as targets of age-related 
dysfunction  (Marques, Sousa et al. 2013). AD and CTE are similarly marked by accumulations 
of amyloid beta (Aβ) and phosphorylated tau (p-tau), although they have distinct regional and 
temporal patterns.  While specific transporters and receptors have not yet been clearly identified, 
new research suggests the ependyma is involved in both Aβ and p-tau clearance  (Matsumoto, 
Chiba et al. 2015, Ueno, Chiba et al. 2016). Therefore, it is likely that damage to the ependymal 
lining may contribute to accumulation of Aβ and p-tau in diseases such as AD and CTE.   
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Alterations to the ependymal lining in aging 
 
Alterations to the ependymal lining, including ependymal cell loss or destruction, are found in 
aging, injury and neurodegenerative disease. Our studies (Chapter 2, Shook et. al. 2014) along 
with others, have shown periventricular areas devoid of ependymal cells are typically marked by 
prominent gliosis along ventricle surface, displaying dense astrocytic processes marked by the 
intermediate filament glial fibrillary acidic protein (GFAP)  (Del Bigio 2010) (Figure 1B). 
Reactive astrocytes that replace denuded ependymal cells are proposed to be an attempt to 
reestablish homeostasis at the CSF/ISF interface  (Roales-Buján, Páez et al. 2012). However, 
while periventricular astrocytes partially resemble the ependymal lining by forming CSF-
contacting microvilli and other similar features related to ependymal cell barrier functions, the 
astrocytes do not contain motile cilia nor do they display the same basolateral polarization of 
AQP4 water channels that is characteristic of ependymal cells  (Jiménez, Domínguez-Pinos et al. 
2014). Studies in our lab using mice have found modest ‘ependymal repair’ occurs in specific 
regions of the ventricle wall in aging, and that ependymal-like cells can be generated in response 
to injury (Luo et al. 2008). However, these studies were performed in mice, and it is important to 
consider that humans may not have the same regenerative capacity as rodents due to differences 
in the underlying neurogenic niche, the subventricular zone (SVZ). The changing composition of 
the rodent and human SVZ in aging is illustrated in Figure 1. In mice, an intact ependymal 
lining is maintained and SVZ neurogenesis persists throughout aging, albeit at reduced levels 
(Luo et al., 2006)  (Capilla‐Gonzalez, Cebrian‐Silla et al. 2014) (Figure 1A).  In contrast, the 
adult human SVZ capacity is more limited, displaying a reduced number of neural stem cells 
with apical processes contacting the CSF and an absence of progenitor pools (Sanai et al., 2011; 
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Wang et al., 2011) (Figure 1B).  The human SVZ structure differs further compared to rodents 
due to the presence of a hypocellular ‘gap’ region adjacent to the ependymal lining thought to be 
the remnant path of neuroblasts migrating during post-natal development  (Capilla‐Gonzalez, 
Cebrian‐Silla et al. 2014). The ‘gap’ region is followed by a band of astrocytes, referred to as 
the ‘astrocytic ribbon’ (Sanai et al., 2004; Zecevic, 2004; Guerrero-Cazares et al., 2011). Why 
astrocytes remain clustered as an ‘astrocytic ribbon’ is not clear, especially since astrocytes in 
the brain parenchyma tend to ‘tile’ and do not typically cluster together, except in the cases of 
injury or lesion where a glial scar forms (Sofroniew, 2009).  
Figure 1
 
 
Figure 1. Schematic representations show the cytoarchitectural organization of the mouse (A) 
and human (B) SVZ stem cell niche in young adult and aged adult tissue. 
 
Previous studies in our lab have demonstrated that along with an intact ependyma, ventricle 
volume remains constant throughout aging in mice (Shook et al., 2014).   The studies I 
conducted show that humans, on the other hand, tend to have large regions of gliosis along the 
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ventricle lining in aging, and also have age-related ventricle expansion.  The studies presented in 
Chapter 2 investigate the link between ependymal gliosis and ventricle expansion.   
 
New discoveries highlight importance of ventricular system health 
Recent advances using a combination of neuroimaging, molecular and cellular techniques have 
shown that ventricular system functions are much more complex than previously recognized  
(Brinker, Stopa et al. 2014). The traditional view of ventricular system flow dynamics suggests 
the majority of CSF is reabsorbed into venous circulation through arachnoid granulations into the 
superior sagittal sinus, with a small portion entering cervical lymphatics along the cranial nerves. 
This classical model of directed bulk flow movement of CSF is now being reconsidered, with 
new research questioning flow rate and primary locations of CSF formation and absorption. 
There is also new evidence that other important physiological functions, including the clearance 
of toxic metabolites and restoration of the brain during sleep, may depend on CSF circulation  
(Iliff, Wang et al. 2013, Kress, Iliff et al. 2014, Xie, Kang et al. 2013).  
 
The importance of CSF as part of the functional waste clearance system of the brain and CNS is 
highlighted by the glymphatic system, which was recently identified by the Nedergaard Lab 
(University of Rochester Medical Center, Rochester, NY, USA) by observing the movement of 
fluorescent tracers into the brains of living mice.  The glymphatic clearance pathway performs a 
similar function to the lymphatic pathway of the body, but relies on glial cells, hence the name 
glial + lymphatic. The glymphatic pathway allows CSF to wash over the brain parenchyma to 
help clear ISF and extracellular solutes from the interstitial spaces  (Iliff, Wang et al. 2013).  The 
pathway allows CSF to enter the brain along para-arterial spaces then exit along para-venous 
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spaces.  The movement of fluid through the parenchyma is assisted by convective bulk flow of 
ISF and facilitated by AQP4 water channels along astrocytic endfeet that line the vasculature, 
guiding the flow of fluid along the outside of blood vessels.    
 
The discovery of the glymphatic system should highlight the importance of the ventricular 
system as a whole, as well as the underlying elements, which include the ependyma.  A well 
functioning glymphatic system is essential for healthy aging, as studies have shown that 
impairments of glymphatic clearance can contribute to toxic accumulations of interstitial solutes 
including Aβ and p-tau  (Kress, Iliff et al. 2014).  
 
Another recent advancement that has critical implications regarding the potential role of the 
ventricular system in neurodegenerative disease is the discovery of lymphatic vessels in the 
meninges of the brain  (Louveau, Smirnov et al. 2015). The surprising discovery of lymphatic 
vessels around the brain was aided by a new technique in tissue preparation developed by 
Louveau and colleagues that allowed for whole sample visualization of intact tissue. While it 
was previously known that CSF flows into the cervical lymph node, it was not known how this 
occurs. Using injections of Evans blue, Louveau and colleagues demonstrated that the meningeal 
vessels are the primary route for CSF drainage to lymph nodes. The new discovery that 
lymphatic vessels exist in the brain meninges also implies that damage to the meningeal 
lymphatic vessels could have severe implications that are just beginning to be considered. 
Understanding the mechanisms of long-term damage from repeated mild traumatic injuries 
(rmTBI), commonly referred to as concussions, may have particular relevance. It is possible that 
damage to the brain’s lymphatic vessels may cause inefficient drainage of CSF, contributing to 
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the development of neurodegenerative diseases such as AD and CTE through increased pressure, 
inefficient clearance of toxins, or a combination of both. 
 
Together, recent discoveries highlighting the importance of the ventricular system and 
maintaining a healthy ependymal lining in aging may provide new insight into diseases marked 
by ventriculomegaly, which include schizophrenia, alcoholism, bipolar disorder, AD and CTE.  
CTE is believed to be caused by repetitive brain trauma and is of particular interest, because 
unlike the ventricular dilation found in AD that is attributed to ex-vacuo compensation, 
ventricular expansion precedes tissue atrophy in CTE (Kiernan, Montenigro et al. 2015).  
 
Repeated mild traumatic brain injury (rmTBI)  
 
Concussion:  Definition, mechanisms of injury  
Mild traumatic brain injury (mTBI) is used synonymously with concussion.  The 2012 
Consensus Statement on Concussion in Sport put forth the following updated definition:  
“Concussion is a brain injury and is defined as a complex pathophysiological process affecting 
the brain, induced by biomechanical forces”  (McCrory, Meeuwisse et al. 2013).  Biomechanical 
forces of mTBI include blunt impact, acceleration/deceleration, or rapid changes in pressure, 
such as in blast injury. Movement of the brain within the skull can be linear, rotational or a 
combination of both.  Rotational force is considered to be the major component of concussion 
and is linked to symptom severity  (Graham, Rivara et al. 2014). Acceleration and rotational 
forces cause shear force, which is the twisting that occurs when brain areas of different densities 
rotate at different speeds.  Shear force is the cause of diffuse axonal injury, the main form of 
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structural injury following concussion that occurs from axonal stretching  (Barkhoudarian, 
Hovda et al. 2011). The corpus callosum and midbrain structures are most affected by rotational 
forces (Ho et al. 2009, Giordano et al. 2014).   
 
In addition to injury from mechanical forces, concussions generate a pathophysiologic cascade of 
events including neuronal depolarization, release of excitatory neurotransmitters, ionic shifts, 
changes in glucose metabolism, altered cerebral blood flow, and impaired axonal function  (Giza, 
Hovda 2001). These alterations have been correlated with periods of post-concussion 
vulnerability and with neurobehavioral abnormalities.  
 
Symptomatically, immediate neurological impairments following a concussion (i.e., dizziness, 
confusion, disorientation, blurred vision) generally resolve spontaneously. No abnormalities are 
generally found on routine imaging (CT or MRI), which increases the difficulty of diagnosis and 
assessment of severity. While concussion can result in loss of consciousness, the majority of 
cases do not. Symptoms of concussion vary widely and typically resolve within a few weeks 
(McCrory, Meeuwisse et al. 2013). However, history of prior concussion has been found to 
double the risk for prolonged symptoms in football players (Chrisman, Rivara et al. 2013). 
Prolonged symptoms following concussion fall under the diagnosis of post-concussive syndrome  
(Ryan, Warden 2003). 
 
Chronic Traumatic Encephalopathy (CTE) 
CTE is a progressive neurodegenerative disease mainly found in athletes with a history of 
repetitive concussive or subconcussive head injuries. Repeated brain trauma-related dementia 
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was characterized in boxers in 1928 by the term “Punch Drunk”  (Martland 1928) then later 
named “Dementia Pugulistica”  (Millspaugh 1937). The first published report of CTE in a 
professional American football player occurred in 2005  (Omalu, DeKosky et al. 2005). Recent 
neuropathological studies have identified CTE in athletes from various sports including soccer, 
baseball, ice hockey, rugby and most recently, BMX action sports.  Currently, there have been 
approximately 250 confirmed cases of CTE based on post-mortem evaluation identifying the 
pathognomonic p-tau lesions required for conclusive diagnosis  (McKee, Cairns et al. 2016). 
While the majority of cases thus far are in athletes exposed to repeated concussive or 
subconcussive hits to the head, cases have also been confirmed in non-athletes exposed to 
repeated head trauma and in military personnel exposed to blast injury (Stein, Alvarez et al. 
2014). It may be important to note that the majority of military personal diagnosed with CTE 
also played contact sports.  While repeated mild traumatic brain injury (rmTBI) is thought to be 
the main etiology behind CTE, symptoms often do not appear until years following injury  
(Galgano, Cantu et al. 2016). Symptoms associated with CTE include memory loss, confusion, 
impaired judgment, impulse control problems, aggression, depression, and, eventually, 
progressive dementia. Radiotracers are being developed that cross the blood brain barrier and 
bind to neurofibrillary and astroglial p-tau aggregates to allow visualization of p-tau in living 
patients using positron emission tomography (PET)  (Barrio, Small et al. 2015).  However, the 
results of these studies remain controversial due to lack of specificity (Zimmer, Leuzy et al. 
2014), thus, CTE diagnosis can only be made upon post-mortem examination.  Clinical 
guidelines for diagnosing probable, possible and unlikely cases of CTE-related syndrome in 
patients exposed to repeated head trauma have recently been put forth by clinicians under the 
term traumatic encephalopathy syndrome (TES)  (Reams, Eckner et al. 2016).  Recent combined 
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efforts have been made by groups of neurologists to improve clinical and pathological 
classifications for CTE. 
Subtypes and stages of CTE 
A consensus panel of neurologists recently described the defining pathological characteristic of 
CTE as follows: pathognomonic lesions marked by accumulation of abnormal p-tau in neurons, 
astrocytes and cell processes distributed around small blood vessels in an irregular pattern at the 
depths of the cortical sulci  (McKee, Cairns et al. 2016). The report also listed several supportive 
characteristics of CTE that correspond to previously published definitions.  While updates are 
being made on almost an annual basis, currently there are 4 stages of clinical development of 
CTE  (McKee, Stein et al. 2015), and 4 corresponding stages of pathological development 
(Kiernan, Montenigro et al. 2015). 
 
The 4 stages of clinical development of CTE are:  
(i) headache, loss of attention and consciousness 
(ii) depression, explosivity and short-term memory loss 
(iii) loss of executive function and cognition  
(iv) dementia   
 
The stages of clinical development of CTE have been found to generally correspond to the 
stages of pathological development.  The 4 stages of pathological development are marked by 
the following features upon post-mortem examination:  
(i) isolated perivascular foci of p-tau positive neurofibrillary tangles (NFTs) and astrocytic 
tangles in the depths of the sulci and occasional mild ventricular dilation 
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(ii) increasing tauopathy in sulci, and also in deep structures (substantia nigra, dorsal and 
median raphe and thalamus), mild expansion of lateral ventricles and third ventricle, 
cavum septum pellucidum, Mild TDP-43 pathology but no Aβ plaques  
(iii) mild frontal and temporal atrophy, enlargement of the lateral and third ventricles, septal 
abnormalities (50% of cases) including cavum septum pellucidum or fenestrations, 
extensive NFTs are found in the hippocampus, entorhinal cortex, amygdala and 
additional regions, increasing TDP-43 pathology in most cases 
(iv) Severe atrophy in regions including cortex and hippocampus, thinning of corpus 
callosum, septal abnormalities (67% of cases) including cavum septum, fenestrations, or 
absence of the posterior septum. Widespread TDP-43 and P-tau are found throughout 
the brain as irregular clusters of glial tangles and NFTs  
 
Relevant to our investigations, two important features to note that become more common or 
pronounced with advanced stages of pathological development of CTE are (1) increasing damage 
to the septal region and (2) ventricle expansion. Interestingly, ventricle expansion begins in the 
early stages (1 and 2) while atrophy does not occur until later stages (3 and 4).  My research 
presented in Chapter 3 demonstrates that the septal region may be particularly vulnerable to 
injury following repeated brain trauma. Studies presented in chapter 3 also investigate 
ventriculomegaly and ependymal damage in an rmTBI mouse model.   
 
Is damage to the ependymal lining a contributing factor to CTE? 
Ependymal cell integrity may be an overlooked factor involved in the progression of CTE 
symptomology, possibly contributing to ventricular enlargement and p-tau accumulation. It is 
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possible that concussive injuries, whether by impact forces, rapid acceleration/deceleration, or 
rapid changes in pressure (such as in blast injury) cause a fluid wave that propagates through the 
CSF of the ventricle, creating structural damage to ependymal cells  (Xiong, Elkind et al. 2014). 
Seismological predictions suggest mechanical pressure waves would cause more damage to 
large, unsupported objects, such as the motile cilia of ependymal cells that extend into the CSF  
(Toth, Hollrigel et al. 1997). As previously noted, inhibition of ciliary beating has been shown to 
contribute to the development of hydrocephalus in experimental mouse models (Monkkonen, 
Hakumaki et al. 2007). Regional tissue deformation generated by the shear force of tissues of 
varying densities moving across one another during concussive injury can cause stretching or 
tearing, also possibly contributing to periventricular gliosis, inflammation and ependymal cell 
damage. The rationale of our hypothesis that ependymal cell damage is a contributing factor in 
CTE is supported by the studies presented in Chapter 2 that demonstrate ependymal damage and 
subsequent gliosis leads to ventricular expansion in mouse models. The hypothesis is also 
consistent with the four progressive stages of CTE identified by Anne McKee’s group that 
regularly demonstrate ventricular enlargement occurs at early stages of CTE, while mild brain 
atrophy begins to occur in later stages (McKee, Stein et al. 2015, Kiernan, Montenigro et al. 
2015) implying that the pathogenesis of ventricular enlargement is due to factors other than brain 
atrophy.  
 
Under normal conditions, waste molecules in the parenchyma diffuse transependymally into the 
ventricles, and are then either actively cleared by the choroid plexus or cleared by bulk flow 
through drainage into lymph or venous blood (Johanson et al, 2011). Damage to the ependymal 
cells can lead to replacement by astrocytic gliosis along the ventricle lining, creating an altered 
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CSF/ISF barrier. Alterations to the CSF/ISF interface may impair CSF flow, potentially 
disrupting the brain’s ability to cleanse itself of waste molecules including p-tau. AQP4 
localization along astrocytic endfeet that line blood vessels have been shown to facilitate 
glymphatic clearance, and TBI has been shown to disrupt AQP4 polarization (Ren, Iliff et al. 
2013). Further studies by the same group used AQP4-/- mice to demonstrate that disruption to 
glymphatic system functioning can lead to increased accumulation of p-tau and activated 
microglia (Iliff, Chen et al. 2014). Therefore, it is possible that ependymal damage and 
associated changes in barrier function may contribute to ventricular enlargement and/or p-ta 
accumulation following repeated head injury. 
 
While ventricle enlargement is a hallmark structural feature of CTE, no animal model has yet to 
recapitulate this phenotype.  This may be because most rmTBI studies focus on cortical and 
hippocampal neuronal damage and gliosis, neglecting to investigate ventricle volume changes 
and the ependymal lining (see Chapter 5, Figure 1). TBI has been shown to cause reversible 
damage to motile cilia (Xiong, Elkind et al. 2014) but did not lead to ventricle enlargement as the 
cilia was repaired within 1 month and ependymal cells remained intact. A limitation of this study 
is that it only included a single brain injury, and it is possible that repeated injuries could have 
lead to more severe ependymal damage.  
 
Repeated head injury is the main factor linked to CTE; however, the severity and the frequency 
of rmTBI required to cause CTE continues to be elusive (Galgano, Cantu et al. 2016). Thus, 
repeated head injuries are considered necessary to cause CTE, but not sufficient.  In addition to 
the severity of injury and patient characteristics including history of prior concussions, the 
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mechanism of injury is thought to be an important factor in determining clinical outcome 
following concussion (Stemper, Shah et al. 2016). Animal models that recapitulate the 
acceleration and rotational forces of injury are required to improve our understanding of 
neuropathological sequelae of rmTBI.   
Animal models of rmTBI/CTE 
Repeated concussions have been linked to debilitating long-term consequences such as memory 
impairment and emotional instability (McKee 2009, Broglio 2012, Bailes 2013).  Animal models 
of rmTBI that replicate forces of concussion (mTBI) and produce robust modeling of CTE 
disease pathology do not currently exist (Dewitt et al, 2013); however, animal models of rmTBI 
are necessary to help elucidate the pathological mechanisms of CTE, as human tissue studies 
provide end-point analysis only, and neuroimaging studies are still limited.  Ideally, such a 
model would generate the neuropathological features matching human post-mortem tissue with 
CTE, which include p-tau accumulations, neurofibrillary and astrocytic tangles, ventricular 
enlargement, chronic inflammation, and TDP-43 accumulations.  Many studies using animal 
models of rmTBI have been recently published using a variety of impact methods, various 
numbers of hits and different inter-injury intervals (see Chapter 5, Table 1 for list of studies with 
experimental paradigms including hit numbers and intervals).  The majority of these studies use 
C57/BL/J male mice age 2-3months.  The histological findings of the studies vary, and it is clear 
that further improvements need to be made in order to create improved reliable models that 
better replicate human exposure (Turner, Lucke-Wold et al. 2015). 
 
Tissue clearing and three dimensional (3D) imaging 
Technological advances in 3D imaging and new tissue clearing protocols are paving the way to 
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enhance histological investigations in intact tissue specimens, which is of great benefit to 
researchers as biological specimens are inherently 3D.  CLARITY, iDISCO, TDE and CUBIC 
are among the many newly published tissue clearing protocols that are designed to allow deep 
penetration of high quality imaging, which is ideal for investigations assessing regional brain 
injury and periventricular structures.  The studies presented in Chapter 4 demonstrate that 3D 
imaging can be performed consistently to a depth of 120m on 500m thick sections using a 
modified whole mount protocol without tissue clearing for certain antibodies of interest. These 
results pave the way for future studies by enabling researchers to use the baseline images 
provided to evaluate the added value of tissue clearing, which is often difficult because results 
often vary by antibody and sample size.  Different clearing methods are evaluated, as each comes 
with its own benefits and drawbacks, and the iDISCO protocol is tested resulting successful 
clearing but unsuccessful labeling. Applications of advanced imaging and clearing techniques 
will be particularly useful for visualizing structures that span beyond single imaging planes such 
as investigating below the surface of periventricular gliosis and visualizing septal and 
hippocampal changes following rmTBI. 3D imaging of cleared, immunolabeled tissue can be 
applied to injury models to investigate the astrocytic and microglial reaction in scar formation 
within the brain in response to injury.  
Organization of thesis 
My work has focused on histological and structural changes that occur in periventricular regions 
of the brain during aging and following repetitive mild brain injury  
In Chapter 2, by directly linking postmortem human MRI sequences with histological features 
of periventricular tissue, we show that substantial areas of lateral ventricle surface gliosis are 
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associated with ventriculomegaly. To examine whether loss of ependymal cell coverage resulting 
in ventricle surface glial scarring can lead directly to ventricle enlargement independent of any 
other injury or degenerative loss, we modeled in mice the glial scarring found along the lateral 
ventricle surface in aged humans. Together, these studies demonstrated a direct link between 
lateral ventricle surface gliosis and ventricle enlargement, highlighting the importance of 
maintaining an intact ependymal cell lining throughout aging.  
 
In Chapter 3, to advance our understanding of regional and temporal cellular responses to 
repeated mild traumatic brain injury (rmTBI), we used a mouse model of rmTBI that allowed for 
free head and neck movement and incorporated acceleration, deceleration and rotational forces. 
We investigated two protocols, rmTBI-short (5 hits delivered over 3 days) and rmTBI-long (5 
hits delivered over 15 days). The rmTBI-short protocol generated an immediate, localized 
microglial and astroglial response in the dorsolateral septum and hippocampus, with the 
astroglial response persisting in the dorsolateral septum. The rmTBI-long protocol showed only a 
transitory astroglial response in the dorsolateral septum. Our results demonstrate that the inter-
injury interval is a critical factor in determining the magnitude of response, and that the lateral 
septum and hippocampus are particularly vulnerable regions in rmTBI, possibly contributing to 
memory and emotional impairments associated with repeated concussions. 
Chapter 4 explores new methods for obtaining 3D images of intact biological tissue structures 
by creating an optimized whole mount preparation strategy and using advanced imaging 
techniques.  Various tissue clearing protocols are considered, and results from the iDISCO tissue 
clearing protocol are presented. While these studies were performed in the context of young 
wild-type mice, the procedures discussed were devised to enhance histological investigations to 
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better define and visualize the scope of regional injury in rmTBI mouse models, as well as other 
applications.   
In Chapter 5, I summarize the importance of maintaining a healthy ependymal lining and 
discuss implications of gliosis and ventriculomegaly. I provide a review of current rmTBI 
literature, including limitations, significance and implications. This discussion will highlight 
difficulties of modeling CTE in rodents, implications for concussions, future perspective for 
concussion research and applications of 3D imaging.   
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Chapter 2:  Ventriculomegaly Associated With Ependymal Gliosis 
And Declines In Barrier Integrity In The Aging Human And Mouse 
Brain*  
 
 
 
* Excerpted from:  Shook BA1, Lennington JB1, Acabchuk RL1, Halling M, Sun Y, Peters J, 
Wu Q, Mahajan A, Fellows DW, Conover JC.  Ventriculomegaly associated with ependymal 
gliosis and declines in barrier integrity in the aging human and mouse brain. Aging Cell. 
2014 Apr;13(2):340-50. doi: 10.1111/acel.12184. (1 Co-first authors) 
 
Note:  This chapter is comprised of work that was performed in a team effort.  My main 
contribution to this work included the processing and analysis of human tissue, creating and 
compiling figures and assisting with the writing of the publication.  I also assisted with 
processing of MRI scans and mouse tissue.  Sections of the publication to which I did not 
contribute have been removed.  Credit to other graduate students is provided after the legends for 
each figure.   
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 INTRODUCTION 
 
Throughout adulthood and following injury, most epithelial linings of the body display 
remarkable plasticity and show considerable regenerative ability due to their associated stem cell 
niche (Fuchs et al., 2004; Blanpain et al., 2007; Snippert et al., 2010). A proliferative stem cell 
niche, the subventricular zone (SVZ), is also maintained along the lateral wall of the lateral 
ventricles in the adult mouse brain (Doetsch et al., 1997; Tropepe et al., 1997; Jin et al., 2003; 
Enwere et al., 2004; Maslov et al., 2004; Conover & Shook, 2011; Shook et al., 2012), and SVZ 
stem cells can contribute to repair of the lateral ventricle epithelial lining, the ependyma, 
throughout aging (Luo et al., 2006, 2008; Conover & Shook, 2011). However, we found that 
while regenerative stem cell-mediated repair can address the modest ependymal cell loss found 
in aged mice, extensive damage to the ependyma instead results in dense surface gliosis or 
‘scarring’ (Del Carmen Gomez-Roldan et al., 2008; Luo et al., 2008).  
The ependyma provides a bi-directional barrier and transport system for cerebral spinal fluid 
(CSF) and interstitial fluid (ISF) exchange (Del Bigio 2010; Johanson et al. 2011; Roales-Bujan 
et al. 2012), helping to keep the brain toxicant-free and in physiologic balance (Johanson et al. 
2011; Roales-Bujan et al. 2012). The repercussions of periventricular gliosis instead of 
regenerative ependymal cell repair would be significant due to the loss of the bi-directional 
transport system provided by the ependymal cells lining the ventricles (Roales-Bujan et al. 
2012).  
 
Fluid-attenuated inversion recovery-MRI (FLAIR-MRI) scans of aged humans typically show 
ventriculomegaly and periventricular hyperintensities indicative of edema (Fazekas et al. 1993; 
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Sener 2002). While the demise of the ependymal lining has been linked to 
hydrocephaly/ventriculomegaly, and many neurological/psychiatric illnesses (e.g., autism, 
ADHD, schizophrenia) display comorbid ventriculomegaly [(Palha et al. 2012) and references 
therein], the molecular and cellular mechanisms underlying ependymal cell loss and its 
involvement in the initiation or progression of ventriculomegaly or other disease mechanisms 
remain largely enigmatic. It is important to note that the human SVZ stem cell niche, while 
highly active in infancy, dramatically declines by 18 months of age (Sanai et al. 2011; Wang et 
al. 2011; Bergmann et al. 2012), but individual variations are likely to exist. Through aging 
insults such as infectious agents, toxic substances and trauma may result in ependymal cell loss 
(Del Bigio 2010; Johanson et al. 2011), suggesting that stem cell-mediated regenerative 
replacement of lost or damaged ependymal cells is likely not an option in aged humans. As a 
result, loss of ependymal cell coverage and functionality would affect periventricular interstitial 
fluid homeostasis and transependymal bulk flow mechanisms. Since the human brain is larger 
than the mouse, Cserr postulated that there would be a greater dependence on efficient clearance 
of interstitial solutes, particularly larger molecules in humans (Cserr 1971), suggesting that loss 
of a functional ependyma would be of greater consequence to humans (Del Bigio 2010; Johanson 
et al. 2011).  
 
Through an extensive comparison of mouse and human periventricular tissue, we reveal striking 
species-specific differences in the integrity and general maintenance of the lateral ventricle lining 
through aging. In addition, we present the first comprehensive documentation of the aged human 
lateral ventricle apical surface based on whole mount preparations of portions or the entire lateral 
ventricle wall. Findings from human tissue analysis then informed our generation of appropriate 
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models in mice. We show that following extensive insult to the ependymal lining in mice similar 
repair mechanisms do exist between mouse and human, allowing further investigation into the 
association between ventricle surface gliosis and ventriculomegaly.  
MATERIALS AND METHODS 
Animals 
Male CD-1 mice (Charles River, Wilmington MA, USA) were aged in our vivarium; 3-month 
and 20-24-month mice were designated as young adult and aged, respectively. Animal 
procedures were approved by the University of Connecticut IACUC and conformed to NIH 
guidelines.   
Mouse Brain Tissue Immunohistochemistry  
Mice were perfused transcardially with 0.9% saline followed by 4% paraformaldehyde and 
coronal sections (50µm) immunostained, as described (Luo et al. 2008). Goat anti-GFAP (1:250, 
Santa Cruz Biotechnology, Santa Cruz CA, USA); mouse anti-GFAP (1:500, EMD Millipore, 
Billerica MA, USA) and rabbit anti-S100 (1:500, Dako, Glostrup, Denmark) antibodies and 
Alexa Fluor dye-conjugated secondary antibodies (Molecular Probes Life Technologies, Grand 
Island NY, USA) were used. Immunostained sections were imaged on a Zeiss Axio Imager M2 
microscope with ApoTome (Carl Zeiss MicroImaging, Inc., Thornwood NY, USA), with a 
HAMAMATSU ORCA-R2 digital camera C10600 or on a Leica TCS SP2 confocal laserscan 
microscope (Leica Microsystems, Buffalo Grove IL, USA). Secondary antibodies alone were 
used for controls. 
 
Lateral ventricle wall wholemounts were prepared as described (Mirzadeh et al. 2008) and 
imaging protocols of whole mount tissue preparations are as previously detailed (Shook et al. 
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2012). Wholemounts were immunostained with the following antibody combinations: mouse 
anti- -catenin (1:250, BD Biosciences, San Jose CA, USA); rabbit anti- -catenin (1:100, Cell 
Signaling Technology, Danvers MA, USA); mouse or rabbit anti--tubulin (1:500, Sigma-
Aldrich, St. Louis MO, USA); mouse anti-GFAP (1:400, EMD Millipore, Billerica MA, USA); 
goat anti-GFAP (1:250, Santa Cruz Biotechnology, Santa Cruz CA, USA); rabbit anti-AQP4 
(1:400, Sigma-Aldrich, St. Louis, MO, USA) and imaged. The imaging focal plane was set at the 
ventricle surface as determined by the use of -catenin (marks apical adherens junction proteins) 
and -tubulin (marks basal bodies of cilia) as indicators of surface depth.  
Neuraminidase Injections  
Mice were anesthetized using isoflourane and then positioned in a stereotaxic apparatus 
(Stoelting, Wood Dale, IL). Body temperature was maintained using heating pads.  A sterile 
syringe loaded with neuraminidase (Clostridium perfringens, Roche Diagnostics, Indianapolis 
IN, USA) diluted in saline (0.9% NaCl) was delivered unilaterally to the right lateral 
ventricle using the following coordinates relative to bregma (lateral: 0.65mm, ventral: 2.65mm). 
Neuramindase (1 l) was injected at a rate of 0.5μL/min for 2 minutes. Control mice were 
injected with an equal volume of saline.  
 
Lateral Ventricle Volume Measurements: Mouse  
To determine age-related changes in lateral ventricle volume every fourth section (10-12 coronal 
sections total, n=3 per age, coordinates +1.78--1.2mm relative to Bregma) was stained for 
S100 ependymal cells) and imaged. Contour tracings of the ventricle walls and resulting 3D 
models were constructed using StereoInvestigator and Neurolucida Explorer (MBF Bioscience, 
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Williston VT, USA).  To evaluate expansion, the same procedure was used on all sections from 
most anterior to the point when the 3rd ventricle became visible. 
Human Brain Tissue Histology/Immunohistochemistry 
Postmortem human brain tissue (hemispheres and slices) was obtained from the Harvard Brain 
Tissue Resource Center (McLean Hospital) and from the UCHC Department of Anatomic 
Pathology and Laboratory Medicine. Tissue was fixed in 10% formalin (minimum 2 weeks, 
maximum 6 weeks), rinsed thoroughly in 0.1M PBS and wholemounts of the lateral ventricle 
lateral wall were processed for antigen retrieval and immunohistochemistry, as described above. 
Wholemounts of all regions of the lateral ventricle (Subject 1: 36 15mm x 8mm sections and 
Subject 2: 18 15mm x 8mm sections) were prepared as described above. Coronal sections were 
taken from the superior-most region of the anterior lateral ventricle to investigate the integrity of 
the ependymal lining and SVZ. 
 
For immunoperoxidase labeling, 8 m paraffin sections were processed using a Bond Max 
autostainer (Leica Microsytems, Buffalo Grove IL, USA). Hematoxylin and eosin staining was 
performed as described (Luo et al. 2008). 
Lateral Ventricle Volume Measurements: Human  
For evaluation of lateral ventricle volumes across age, high-resolution MRI sets were obtained 
from the Open Access Series of Imaging Studies (OASIS) database (www.oasis-brains.org) 
(Marcus et al. 2007; Marcus et al. 2010). Only male and female subjects remaining non-
demented (clinical dementia rating < 0.5) throughout the length of the study were analyzed 
(Marcus et al. 2007). MRIs of younger individuals (non-demented subjects age 20 to 34-years) 
were obtained from Yale Medical School. In total, 70 individuals were analyzed in six different 
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age groups: 19-39 (n=23), 40-69 (n=6), 60-69 (n=10), 70-79 (n=13), 80-89 (n=13), and >90 
(n=5). The lateral ventricles were defined on high-resolution MRI T1-weighted images using a 
semi-automated 3D segmentation tool, ITK-SNAP (www.itksnap.org)(Snippert et al. 2010). Pre-
processing of the images was performed prior to automatic isolation of the lateral ventricle, 
including setting an upper threshold for image intensity at 30%. For automatic segmentation, 
lateral ventricle expanding balloon force was set to 3.0, detailed curvature force set to 0.20, and 
125 iterations at step size 1 was sufficient to isolate the lateral ventricle. Volumes were rendered 
using Slicer3D [www.slicer.org]. Longitudinal MRI sets (OASIS) were used from healthy 
subjects that underwent MRI scanning in three or more sessions spanning multiple years(Marcus 
et al. 2010). 
Post-Mortem MRI: Human 
Post-mortem MRI was performed using a 1.5 Tesla MR unit (Siemens Avanto, Siemens Medical 
Solutions, Malvern PA, USA). A contiguous thin section (1.3mm), 3-D T1-weighted MP RAGE 
sequence was performed on formalin-fixed brains of two individual subjects. Subject 1 (female, 
82 years) was diagnosed with Alzheimer’s disease and died of pneumonia and Subject 2 (male, 
86 years) died of cardiac arrest. Lateral ventricle volumes were processed and rendered, as 
described above.  
Statistical Analysis  
Results are reported as mean ± SEM. Statistical analysis across multiple ages was assessed using 
1-way ANOVA with Bonferroni's multiple comparisons post-test.  Statistical analysis between 
ages was assessed using a two-tailed unpaired Student’s t-test. Statistical analysis between 
neuraminidase injected and controls was performed using a two-tailed Student’s t-test. Statistical 
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analyses were performed in Prism (GraphPad) software or Excel. Significance was set at p < 
0.05. 
RESULTS 
Humans exhibit age-related lateral ventricle expansion and periventricular gliosis  
Using data from the ‘Open Access Series of Imaging Studies’ (OASIS) database (Marcus et al., 
2007) that included cross-sectional MRI data from young, middle-aged, and older non-demented 
adults, we examined changes to the lateral ventricles. Semi-automated segmentation using ITK-
SNAP (Snippert et al., 2010), followed by 3D reconstruction of the lateral ventricles using 
Slicer3D (www.slicer.org), revealed age-related increases in total volume (Fig. 1A,B). Based on 
longitudinal data from the OASIS collection, which included 150 subjects aged 60–95 years 
(Marcus et al., 2010), we observed sequential age-associated lateral ventricle volume increases in 
both males and females (Fig. 1C,D), similar to other previously reported studies (Scahill et al., 
2002; Resnick et al., 2003). These data illustrate that ventricle expansion occurs in aging even in 
the absence of dementia.  
To evaluate the integrity of the ependymal lining through aging, we examined aged lateral 
ventricle tissue samples collected by the Harvard Brain Tissue Resource Center and the 
University of Connecticut Health Center, Department of Anatomical Pathology (see 
Experimental Procedures, Table 1, Supporting information). Both coronal sections and whole-
mount preparations of the lateral walls of the lateral ventricles were evaluated based on 12 mm 9 
12 mm tissue samples. Tissue was categorized as having (i) intact ependymal cell coverage; (ii) 
dense areas of surface gliosis; or (iii) an intermediate phenotype consisting of a disorganized and 
compromised ventricle lining showing absence of cuboidal ependymal cells as indicated by 
diffuse or absent b-catenin staining (marker of adherens junctions) and the presence of several 
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surface astrocytic processes (see Table 1). Typically, in subjects > 55 years old, a combination 
of both small and large expanses of intact ependymal cell coverage (Fig. 1E,F) and large areas 
devoid of ependymal cells were detected. Staining for glial fibrillary acidic protein (GFAP) 
indicated surface gliosis in regions where an intact ependymal lining was absent (Fig. 1G–I), and 
a dense array of astrocytic processes occupied an enlarged hypocellular region that typically 
defined the narrow subependymal zone (Quinones-Hinojosa et al., 2006), often creating a gliotic 
bulge at the ventricle surface (Fig. 1G–I).  
Whole-mount preparations of the lateral ventricle provide a unique ability to examine the apical 
surface of the ventricle wall and have been used to observe the organization of ependymal cells 
and surface- projecting neural stem cells in mice (Mirzadeh et al., 2008). Here, we used whole-
mount preparations to characterize alterations that occur to the surface ependymal cell layer 
(Doetsch & Alvarez-Buylla, 1996; Conover et al., 2000) in aged human tissue samples. Our 
analysis revealed both zones of contiguous ependymal cell coverage and regions of extensive 
gliosis (Fig. 1J–M). While these studies indicate that surface gliosis occurs in regions where 
ependymal cell coverage has been lost and this phenotype is prominent in tissue from aged 
humans, these studies provided only limited information because accompanying measurements 
of ventricle volumes were not available.  
Pairing Postmortem MRI with Histological Analysis of Periventricular Tissue Reveals 
Association Between Gliosis and Ventriculomegaly 
 
To examine directly the relationship between ventriculomegaly and glial scarring at the ventricle 
surface in human tissue, we paired postmortem MRI scans with histological processing of 
periventricular tissue. Two age-matched subjects were selected based on dramatic differences in 
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lateral ventricle volumes. A contiguous thin section (1.3mm), 3D T1-weighted MP RAGE 
sequence was performed on the formalin-fixed brains of the two subjects. Automatic 
segmentation of the lateral ventricles defined on high-resolution MRI was performed using ITK-
SNAP (Snippert et al. 2010) and volumes rendered using Slicer3D. 3D reconstructions showed 
that Subject 1 (82-years) had an age-appropriate lateral ventricle volume (59241.4mm3) (Subject 
1 volume indicated in red on graph in Fig. 1B, see also Fig. 2A). Local microscopic features of 
periventricular tissue were then mapped using corresponding lateral ventricle tissue processed 
for histology (Fig. 2B-D). Both coronal sections (Fig. 2B) and 15mm x 8mm en face whole 
mount samples (Fig. 2C) were analyzed, effectively covering the entire lateral ventricle lateral 
wall. Tissue samples from Subject 1 contained regions showing an attenuated ependymal cell 
lining (Fig. 2B) and immunohistochemical analysis of whole mount preparations of the lateral 
ventricle wall revealed that while the inferior portion of the anterior and middle wall consisted 
mainly of intact ependymal cell coverage (Fig. 2C, D, green), ‘islands’ of dense gliosis were 
found scattered throughout (Fig. 2C, D, red). In the superior/anterior region, large areas of 
‘mixed’ composition were detected. These regions were comprised of areas of surface gliosis 
(red); isolated areas containing intact ependyma (classic cobblestone appearance, green); and 
regions lacking an intact ependyma as marked by absence of clear -catenin+ surface adherens 
junctions, surface astrocytic processes, but no overt gliosis (compromised, yellow) (Fig. 2D). 
Along the superior (mid and posterior) and entire posterior lateral ventricle wall, large GFAP+ 
gliotic expanses predominated (Fig. 2C, D, red).  
 
In contrast, MRI scans from Subject 2 (86-years) showed a ventricle volume (11279.5mm3) more 
typical of a 20-40 year old (Subject 2 volume indicated in red on graph in Fig. 1B, see also Fig. 
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3A). Hematoxylin and eosin staining of coronal sections of the anterior wall revealed a 
monolayer of cuboidal ependymal cells, indicative of a healthy ependymal lining (Fig. 3B). 
Whole mount preparations of the entire lateral ventricle from Subject 2 revealed intact 
ependymal cell coverage along the complete lateral wall of the lateral ventricle (Fig. 3C, green); 
we did not detect any gliosis along the lateral wall.  
 
To examine whether the two Subjects showed differences in dividing cells within the SVZ, we 
labeled fixed tissue samples with Ki67 to mark cycling cells. We found only a few Ki67+ 
endothelial cells; no other SVZ cells were labeled in either Subject 1 or 2. As with all end-state 
fixed tissue samples, it is impossible to determine if any differences in cycling cells may have 
existed at earlier time points for the two subjects.  
 
The thickness and density of the astrocytic ribbon layer and hypocellular gap region of the two 
Subjects were also compared. No significant differences were observed in regions containing an 
intact ependymal cell lining (data not shown). However in regions lacking ependymal cell 
coverage (Subject 1), large masses of ventricle-contacting astrocytic processes formed increasing 
the thickness of astrocyte coverage from the glial ribbon to the ventricle surface. Whole mount 
preparations allowed us to observe clearly areas of intact ependymal cell coverage, regions with 
some superficial glial processes and other regions with extensive surface glial scarring with no 
ependymal cell coverage.  
Generation of a Mouse Model of Periventricular Gliosis 
 
The directionality of the relationship between ventricle surface gliosis and ventricle expansion 
cannot be easily deduced from MRI scans and endpoint human tissue histology. To investigate 
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this relationship we needed to replicate in mice the phenotype of periventricular glial scarring 
found in aged humans. Under normal conditions we never observed periventricular gliosis in 
mice of any age. Whole mount preparations of the entire lateral ventricle lateral wall consistently 
revealed an intact ependymal cell lining with no gliosis. However, damage to the ependymal cell 
monolayer by intraventricular injection of high concentrations of neuraminidase (100-500ng/ l) 
caused large stretches of ependymal denudation, resulting in extensive gliosis along the ventricle 
surface (Del Carmen Gomez-Roldan et al. 2008; Luo et al. 2008). Neuraminidase, found in a 
range of organisms including bacteria and viruses, cleaves sialoglycoproteins involved in cell 
recognition and adhesion (Rutishauser & Jessell 1988; Kuchler et al. 1994; Figarella-Branger et 
al. 1995) and can thereby mimic ependymal loss due to infection [(Johanson et al. 2011) and 
references therein]. By titering the neuraminidase concentration, varying degrees of ependymal 
cell denudation can be generated to yield differing levels of ventricle surface gliosis (Luo et al. 
2008). We found that 10-50mU resulted in ventricle surface scarring similar to that typically 
found in aged humans (Fig. 1). Immunohistological analysis of the lateral ventricle wall showed 
an increase in astrocytic process density at the lateral ventricle surface in the form of scars (Fig. 
4A, arrows), similar to that found along the surface of the lateral ventricles in aged humans (Fig. 
1J & M, Fig. 2C, Fig. 4B). No scarring or damage was detected in the 3rd or other ventricles, 
indicating a direct and local effect of the intraventricular injections. In addition, loss of the 
ependymal lining resulted in loss of the associated SVZ stem cell niche [(Luo et al. 2008; 
Jimenez et al. 2009; Rodriguez et al. 2012) and references therein]. With this mouse model we 
could then investigate the connection between periventricular gliosis and ventriculomegaly and 
begin to dissect the cellular mechanisms that lead to ventricle surface gliosis.  
Aquaporin-4 is Upregulated in Sites of Lateral Ventricle Gliosis in Mouse and Human 
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Along with ventricle enlargement, FLAIR-MRI of elderly human brains consistently reveals age-
associated periventricular edema (Leys et al. 1990), suggesting that transependymal bulk flow is 
compromised. To assess periventricular scarring and compromised CSF-interstitial fluid 
homeostasis in aged human tissue, we analyzed aquaporin-4 (AQP4) expression patterns. 
Aquaporins are water channels and AQP4 is expressed throughout the brain on perivascular 
astrocytic endfeet and on the basal surface of ependymal cells (Haj-Yasein et al. 2011; Iliff et al. 
2012). AQP4 expression has been found to increase during gliosis (Sofroniew 2009). Deletion of 
AQP4 has been shown to reduce the effects of cytotoxic edema and improve outcome after 
stroke (Sofroniew 2009; Zador et al. 2009). Therefore, changing expression patterns would 
suggest alterations to CSF-interstitial fluid regulation (Papadopoulos & Verkman 2007; Haj-
Yasein et al. 2011; Iliff et al. 2012).  We found high levels of AQP4 in aged human tissue at 
sites of glial scarring, but not where there were intact ependymal cells (Fig. 4B).  Similarly, 
following neuraminidase treatment, we found substantially enhanced expression of AQP4 in 
regions of periventricular scarring in mouse tissue   (Fig. 4A, left of dotted line), but no increase 
in AQP4 expression in the uninjured tissue (Fig. 4A, * area of intact ependymal cells). By 
demonstrating that increased AQP4 expression occurs in periventricular scarring in both mouse 
and humans, our studies indicate the bi-directional fluid transport of CSF/ISF may be altered in 
aged humans, which may contribute to periventricular edema.   
Extensive Ventricle Surface Gliosis Results in Ventricle Expansion 
 
We next examined the possibility that loss of ependymal cells lining the ventricle can initiate 
ventricle expansion, independent of neurodegeneration or other injury to the brain. 
Neuraminidase (50mU, 1 l at 500ng/ l) or saline vehicle (1 l) was injected unilaterally into 
the lateral ventricle of young adult mice (3-4 months). After a two-month period the brains were 
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collected and sectioned. Upon visual inspection, the lateral ventricles of mice injected with 
neuraminidase appeared dilated compared to the lateral ventricles of mice injected with the same 
volume of saline vehicle (Fig. 5A). Contours were traced around the lateral ventricles and then 
uploaded into Neurolucida Explorer software for compilation into 3D reconstructions (Fig. 5B). 
Lateral ventricle volume measurements determined from the 3D models revealed that mice 
injected with a dose of neuraminidase sufficient to denude regions of ependymal cells similar to 
that found in aged humans were significantly larger than both saline-injected (p=0.025) and non-
injected littermates (p=0.024) (Fig. 5C).  Ventricle surface gliosis was verified using 
immunohistochemistry two months after introduction of neuraminidase into the lateral ventricles 
(Fig. 5D, bracket). 
 
DISCUSSION  
The ventricular system of the brain is a network of communicating cavities that encloses and 
circulates the CSF. Together with the blood-brain barrier the ventricles are responsible for solute 
clearance from the brain. Interstitial solutes are thought to be cleared to the CSF via convective 
bulk flow of ISF, and a recently described ‘glymphatic’ pathway has been identified for the para-
aterial influx of sub-arachnoid CSF into the ISF for further clearance along large-caliber draining 
veins that function together with and support other clearance routes (Iliff et al. 2012). 
Biochemical changes in the brain are thereby reflected in the CSF and any alterations to the 
ependymal monolayer would affect efficient bi-directional transport and clearance mechanisms.  
The functional units of the ventricles are the ependymal cells, which are organized as a 
monolayer of ciliated epithelial cells that provide both barrier and filtration functions, and 
generate laminar flow of CSF at the ventricle surface. We examined the relationship between 
 Acabchuk Dissertation 36 
partial loss of the ependymal cell lining of the lateral ventricle to surface gliosis and ventricle 
expansion, and found that significant ventricle surface gliosis can be linked directly to lateral 
ventricle expansion, independent of any injury or degenerative loss of brain tissue. Increased 
expression of the water channel AQP4 was detected in sites of glial scarring, suggesting 
abnormalities in CSF/ISF homeostasis and interstitial solute clearance. Our work and the work of 
others suggests that the effects of replacing functional ependymal cells with a glial scar would be 
cumulative over time, supporting in part the progressive nature of ventriculomegaly (Sival et al. 
2011). While we show that destruction of the ependymal lining alone is sufficient to initiate 
lateral ventricle expansion, it is likely that a combination of factors, such as neurodegeneration, 
vascular defects and the inappropriate accumulation of soluble proteins work in concert to 
generate ventriculomegaly found in humans.  
 
Lateral Ventricle Ventriculomegaly and Periventricular Gliosis in Aging Humans 
In aging humans there is a strong correlation between lateral ventricle ventriculomegaly, not 
involving dementia or obstruction of CSF flow, and aging (Scahill et al. 2002; Resnick et al. 
2003). However, the exact cause, progression and importantly the impact to normal brain 
function are currently not known. Along with ventricle enlargement, FLAIR-MRI consistently 
reveals age-related periventricular edema, suggesting that transependymal flow is compromised. 
Through lateral ventricle volume measurements and 3D modeling using MRI scans from the 
OASIS database of non-demented humans (Marcus et al. 2007; Marcus et al. 2010), we 
demonstrated age-associated lateral ventricle enlargement, with longitudinal data typically 
showing progressive increases in lateral ventricle size. Based on histological analysis of 
postmortem forebrain tissue samples from a population of aged subjects, we found that 
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widespread gliosis along the lateral ventricle walls is typically found. However, these initial 
studies were incomplete, since access to both longitudinal MRI sequence data and tissue samples 
for histological analysis of the entire lateral ventricle wall were not available.  
 
In two contrasting case studies involving brain samples from elderly subjects, we were able to 
analyze post-mortem MRIs paired with histological tissue samples of the entire lateral ventricle. 
This pairing was unique since the two subjects showed significant differences in ventricle 
volume, which gave us the rare opportunity to examine tissue quality along the entire surface of 
the lateral ventricles. Our findings of regional glial scarring at the ventricle surface in the 
expanded ventricle sample and the complete absence of scarring and presence of an intact 
ependymal lining in the small ventricle sample supported our hypothesis that gliosis is associated 
with ventriculomegaly and not solely age. However, the sequence of events that led to gliosis at 
the ventricle surface and ventriculomegaly could not be deduced from this single endpoint 
analysis of lateral ventricle volume and surface histology. Ultimately, reconstruction of medical 
histories, together with a multi-modal imaging paradigm including longitudinal FLAIR-MRI to 
show areas of edema and volume changes, and diffusion tensor imaging (DTI), to show changes 
in major fiber tracts, would provide the level of criteria over the lifetime of the subject necessary 
to validate histological findings and map directionality in a correlation. So while there is no clear 
way to prove causality in the human cases we investigated, the information we obtained 
informed and guided our mouse model strategies.  
Periventricular Tissue Comparisons: Mouse Versus Human   
Due to limited availability of longitudinal, multi-modal human subject data and complete 
histological samples of the ventricle linings, we were reliant on animal models to examine the 
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relationship between ventricle enlargement and periventricular gliosis. Our comparison of mouse 
and human periventricular tissue through aging revealed some striking species-specific 
differences. In adult mice, the lack of significant age-associated change in lateral ventricle 
volume, only limited levels of ependymal cell stretching (measured as increased apical surface 
area) and the capacity for modest ependymal repair through SVZ stem cell-mediated 
regenerative replacement of ependymal cells supports our finding of an intact ependymal cell 
lining with no surface gliosis or scarring throughout aging (Luo et al. 2006; Luo et al. 2008; 
Bouab et al. 2011). It should be noted that caged mice do not experience infection or trauma that 
may result in denudation of the ependymal lining. Periventricular gliosis occurred only in 
situations when we deliberately created extensive injury to the ependymal lining.  
 
Humans, in contrast, do not appear to possess an active stem cell niche in adulthood (Sanai et al. 
2011; Wang et al. 2011; Bergmann et al. 2012) and endothelial cells were the only proliferative 
cells we found within the SVZ of aged human tissue that we surveyed, regardless of ventricle 
size. These studies are in agreement with the work of others describing few proliferating cells in 
the adult human SVZ (Sanai et al. 2004; Sanai et al. 2011); however, the existence and quantity 
of quiescent SVZ stem cells in the adult human remains a point of controversy (Curtis et al. 
2007; Sanai et al. 2007). Interestingly, aged, non-demented humans (>60 years), in contrast to 
mice, typically show age-associated ventriculomegaly and accompanying ventricle surface 
gliosis (Scahill et al. 2002; Resnick et al. 2003). However, some level of variability may exist 
between humans, as we report no periventricular gliosis along the lateral wall of the lateral 
ventricles in an 86 year old who also did not show enlarged lateral ventricles. This subject died 
of a cardiac arrest and did not show any cortical brain atrophy. So, it is possible that this subject 
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did not experience the one or several inciting events that typically result in ventricle surface 
gliosis in the human population. We did not find any overt difference in cycling cells or 
cytoarchitecture in the subependymal layer in regions containing an intact ependyma between 
Subject 1 and 2. However, this was based on a snapshot view at the end of life; it is possible that 
at an earlier (maybe even mid-life) stage there were differences in stem cell number or capacity 
for repair between the two Subjects. The repercussions of periventricular gliosis instead of 
regenerative repair would seem significant, since loss of a bi-directional transependymal 
transport system appears to be inextricably linked to periventricular edema, loss of ISF 
homeostasis and proper solute clearance (Roales-Bujan et al. 2012).  
Generating Mouse Models of Periventricular Scarring  
 
Mouse studies help us to interrogate the human condition variable by variable. Here we isolated 
one variable, ependymal cell denudation resulting in glial scarring at the ventricle surface, to 
examine whether this alone could result in ventricle enlargement in the adult lateral ventricles. 
Bacterial and viral infections are known to cause destruction of the ependymal lining (Johanson 
et al. 2011). Neuraminidase, a surface enzyme associated with bacteria and viruses, can result in 
ependymal cell denudation following severe infection. Previous studies have shown that 
ependymal cell denudation via injection of high concentrations of neuraminidase into the lateral 
ventricle resulted in glial scarring at the ventricle surface and in some instances SVZ cells 
(neuroblasts) formed clusters where there were breaks in the ependymal lining (Del Carmen 
Gomez-Roldan et al. 2008). By titering the concentration of neuraminidase injected into the 
lateral ventricles, we could control the degree of ependymal cell denudation (Luo et al. 2008) 
and generate levels of ventricle surface gliosis to mimic what we detected in human tissue. At 
the concentration and volume used in this study, we only observed glial scars at the surface and 
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never detected any damage to the ependymal lining in the 3rd ventricle and ventricle system 
communication was maintained. Thus we developed an effective and clinically relevant mouse 
model to examine the mechanics and consequences of scar formation. Indeed studies have 
identified abnormal or mis-expression of adherent junction proteins as a cause for ependymal 
denudation in human fetuses [(Sival et al. 2011; Rodriguez et al. 2012) and references therein]. 
We found that the ventricle surface scars generated in mice were very similar to those observed 
in human tissue and showed upregulation of AQP4 expression patterns at sites of ventricle 
surface gliosis. This is of particular significance as AQP4 is implicated in water uptake into brain 
tissue during the development of cytotoxic edema, as well as in water clearance after vasogenic 
edema (Papadopoulos & Verkman 2007; Verkman 2008; Haj-Yasein et al. 2011). In glial scars 
the expression and localization of AQP4 constitutes a neuropathological condition resulting in 
disturbed interstitial bulk flow and failure to clear neurotoxic solutes (e.g., A, tau) [(Verkman 
2008) and references therein]. Reduced brain swelling and improved clinical outcome occurred 
in AQP4-/- mice in a model of bacterial meningitis (Papadopoulos & Verkman 2007); 
demonstrating that altered AQP4 expression may be a maladaptive response that exacerbates 
periventricular water accumulation. The water-transporting function of aquaporins has also been 
implicated in the initial formation of glial scars, affecting both the migration to the site of injury 
and the rate of glial scar formation [(Verkman 2008) and references therein]. This feature may be 
critical and in its absence result in the inability to properly seal the ventricle lining following 
denudation of ependymal cells. Ultimately, AQP4-/- mice in combination with our neuraminidase 
model should provide further mechanistic insight into the phenomenon of age-related ventricular 
enlargement. 
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Conclusion 
Mice possess an active subventricular zone stem cell niche that is capable of modest ependymal 
repair throughout aging. Ependymal cell integrity and barrier function appear to be maintained 
and age-related changes in lateral ventricle volume are not detected in mice. In contrast, aged 
humans appear to lack a functional SVZ stem cell niche and typically develop ventriculomegaly 
during the course of aging. Unlike other epithelial linings of the body, the regenerative 
replacement of the human lateral ventricle ependymal lining would appear to be very limited. 
Since many diseases or injuries (Alzheimer’s disease, schizophrenia, traumatic brain injury, etc.) 
can result in ventricle enlargement, we aimed to establish some of the underlying characteristics 
of ventriculomegaly and found that damage to the ependymal lining resulting in lateral ventricle 
surface gliosis is one potential initiator of ventriculomegaly.   
 
Future studies incorporating non-invasive imaging for assessing ventricle lining integrity and 
interstitial solute movement following perturbations to the ventricle lining will be necessary to 
establish the time course for decline of ventricle lining health and the progression of ventricle 
enlargement. Since we observed regional differences in the integrity of the ventricle lining in 
humans, it will be of particular value to determine whether there is regional vulnerability along 
the ventricle surface. Together our studies highlight the importance of ventricular system health 
in maintaining critical barrier and filtration functions within the brain – a surprisingly 
understudied area in brain barrier biology. 
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FIGURES AND LEGENDS  
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Figure credits:  RA 
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Figure 1 
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Figure 1 Continued.
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Figure 1. Increased ventricle volume and periventricular gliosis are typically associated 
with age in humans. (A) Representative MRI-based 3D reconstructions of the lateral ventricle 
from humans of different age groups. (B) A cross sectional sampling of MRI scans from the 
OASIS dataset (non-demented) demonstrates increased lateral ventricle volume is associated 
with age.  (Subject 1 and 2 volumes are denoted with red dots). (C) Longitudinal data shows 
expansion typically occurs over time in both males and females. (D) MRI-based lateral ventricle 
reconstructions show example of regional expansion (red) over time. (E,F) From aged tissue, 
periventricular, coronal section stained with H&E and whole mounts preparations of the lateral 
wall of the lateral ventricle show regions of intact ependyma. (G) H&E staining of representative 
coronal sections of aged tissue (77 yrs old) clearly show areas devoid of an intact ependymal 
layer (bracket). (H) Enlarged region denoted in (G) shows regions lacking ependymal cells and 
(I) immunohistochemical analysis reveals that areas without an ependymal monolayer have 
GFAP+ processes at the ventricle surface. (J) Whole mount preparation (tissue from 62 year old) 
revealed areas of intact ependyma (K) and large expanses of GFAP+ processes (L, M) – 
magnification of contiguous sheets of ependymal cells (K), ependymal cells with small GFAP+ 
clusters (L), and regions of extensive gliosis (M). Scale bars, 25m (F), 500m (G, I) and 
100m (H, K); and 200m (J). Figure credits:  BS, JL, RA, YS. 
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Figure 2 
 
Figure 2. Large ventricular volume is associated with widespread gliosis at the ventricle 
surface in humans. (A) MRI-based 3D reconstructions of the lateral ventricle for Subject 1. (B) 
H&E staining of periventricular tissue revealed a compromised ependymal cell lining of mixed 
cell composition, including areas devoid of ependymal coverage (arrows indicate separation 
between nuclei of ependymal cells). (C) Representative regional images from extensive 
immunohistochemical analysis of the ventricle surface revealed that while some areas with 
normal ependymal cell coverage were present (green* in IHC image, green in schematic), large 
expanses of gliotic scarring at the ventricle surface (schematic: red) predominated. (D) Coded 
schematic of entire lateral wall of the lateral ventricle, with red indicating areas of astrocytic 
gliosis, yellow indicating a compromised ependymal lacking a distinct layer of cuboid 
ependymal cells, and green indicating intact ependyma. Scale bars, 100m (B); 40m, confocal 
image (C); 1mm, schematic (C).  Figure Credits: RA, MH, BS. 
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Figure 3 
 
Figure 3.  An intact ependyma is found along the entire ventricle surface in the elderly 
subject with a small volume ventricle. (A) MRI-based 3D reconstructions of the lateral 
ventricle for Subject 2. (B) H&E staining revealed a robust ependymal monolayer and (C) 
immunohistochemistry of whole mount preparations showed uninterrupted ependymal cell 
coverage with no surface gliosis. Scale bars, 100m (B); 40m, confocal image (C); 1mm, 
schematic (C).  Figure Credits: RA, MH, BS. 
 Acabchuk Dissertation 48 
Figure 4 
 
Figure 4. In mice, neuraminidase-induced ependymal cell denudation leads to gliosis at the 
ventricle surface and upregulation of AQP4, similar to AQP4 labeling in glial scars found 
along ventricle wall in aged humans. (A) Following intraventricular injection of 
neuraminidase, areas of gliosis (GFAP+, denoted by arrows and demarcated by the dotted line) 
show increased expression of AQP4. Ependymal cells (*) show low levels of AQP4 staining in 
non-scarred regions. (B) Similarly, in human tissue, areas of surface gliosis (arrows, demarcated 
by the dotted line) in human tissue show increased expression of AQP4, whereas areas of 
ependymal cell coverage (*) are marked by -catenin and low levels of AQP4. Scale bars, 
100m (A); 50 m (B).  Figure Credits: RA, MH. 
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Figure 5 
 
Figure 5. Extensive ventricle surface gliosis results in lateral ventricle enlargement in mice. 
(A) Two months after intraventricular injection of neuraminidase lateral ventricles are 
significantly larger (V, ventricle). (B) Contours traced around the ventricles were complied to 
create 3D reconstructions to determine lateral ventricle volumes (* denotes adhesion between 
lateral and medial walls). (C) Ventricle volumes at two months post-injection were larger in 
mice that received neuraminidase compared to mice injected with saline or the uninjected 
littermates (n=5 for neuraminidase (NA) group, n=3 for saline and uninjected controls, * p<0.03) 
Student’s t-test). (D) Immunohistochemistry confirmed gliosis at the ventricle surface (bracket) 
and showed that it persisted two months after neuraminidase injection. Data are means, error bars 
are SEM. Figure Credits: MH, RA. 
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Chapter 3:  Repeated Mild Traumatic Brain Injury Causes Focal 
Response in Lateral Septum and Hippocampus*  
 
 
 
*From publication:  Acabchuk RL, Briggs D, Angoa-Pérez M, Powers M, Wolferz Jr. 
R, Soloway M, Stern M, Talbot LR, Kuhn DM, Conover JC, Repeated Mild Traumatic Brain 
Injury Causes Focal Response in Lateral Septum and Hippocampus, In Press, Concussion  
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INTRODUCTION: 
Mild traumatic brain injury (mTBI), frequently referred to as “concussion”, is a major public 
health concern due its prevalence, especially in youth sports. Estimates based on emerging data 
suggest that the likelihood of a concussion in a single season of youth, high school or collegiate 
football is 1 in 30, 1 in 14 and 1 in 20 players respectively [1]. A growing body of evidence 
suggests repeated incidents of concussive and sub-concussive blows, described as repeated mTBI 
(rmTBI), cause more significant neurological damage than a single mTBI, including longer 
recovery time and a higher likelihood of subsequent brain injury [2-5]. rmTBI has also been 
linked to debilitating long-term consequences such as memory impairment, emotional instability 
and the progressive neurodegenerative disease chronic traumatic encephalopathy (CTE) [6-8].  
 
In animal models of rmTBI the hippocampus, corpus callosum, amygdala and cortex are the 
regions most commonly examined for histological changes [9-12]; however, histological analysis 
has not been exhaustive, so this list may be incomplete and possibly should include other 
regions. Computer-generated modeling of human concussion demonstrates ‘hot-spots’ of impact 
strain just below the sulci at interfaces of gray and white matter [13] and finite element modeling 
of 58 reconstructions of concussive impacts in the National Football League (NFL) predicts the 
largest strain in the corpus callosum [14]. Based on acceleration-deceleration and rotational 
forces causing tissues of varying densities and compositions to move at different speeds (shear 
force) and from finite element modeling data [13, 14], we predicted that areas associated with 
gray and white matter interfaces would be most vulnerable and at highest risk for acute/primary 
injury. In order to determine which regions of the brain are most adversely affected by rmTBI, 
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we performed a comprehensive multi-region investigation of the brain following injury using a 
rotational model of rmTBI.  
 
In order to replicate accurately the rapid acceleration/deceleration and rotational forces common 
in sport concussions, we selected a mouse model that employs an unrestrained closed-skull 
modified weigh drop method that results in 180° free rotation [15]. To enhance clinical 
relevance, we compared two protocols that varied in the time intervals between injuries. We 
investigated regional and temporal histological alterations following rmTBI including 
astrogliosis, microglial activation, phosphorylated tau accumulation and axonal injury. We also 
examined changes in ventricle volume and integrity of the ependymal cell lining, as ventricular 
expansion is a common feature of CTE. We found that the dorsal lateral septum, immediately 
below the corpus callosum and adjacent to the lateral ventricles, is the most dramatically affected 
region. The hippocampus displayed similar cellular changes, but to a lesser degree.  Our results 
support the inclusion of the lateral septum as a region of particular interest in rmTBI research 
and highlight the dangers of repetitive head injury occurring in rapid succession.  
MATERIALS AND METHODS: 
Animals.  All animal procedures were approved by the Wayne State University IACUC and 
conformed to NIH guidelines. Male CD-1 mice (Charles River, Wilmington, MA, USA) were 8 
weeks of age at the beginning of experiments and weighed between 30-35 grams. Strain 
selection was based on previous documentation of consistent ventricle volumes in CD-1 mice 
[16]. To adhere to the investigation of “mild” TBI, mice demonstrating signs of skull fracture or 
hemorrhage were excluded from all experiments.  Skull fractures and hemorrhage were assessed 
upon sacrifice following perfusion by manually inspecting skull integrity and by visually 
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inspecting for blood accumulation on the surface or within the brain during sectioning.  Mice 
presenting signs of skull fracture (SF) and/or hemorrhage (H) were discarded from all 
experiments. Rates of SF and/or H for the rmTBI-short protocol were 11% SF, 3% H and 22% 
SF+H. No skull fractures or hemorrhage were observed with the rmTBI-long protocol.  
 
rmTBI Protocols.  A closed-skull rmTBI was administered as previously described [12] with 
the following improvements:  the tin foil platform was replaced with a transversable ‘trap door’ 
platform magnetically bound and calibrated to the animal's weight to reduce resistance to 
acceleration following impact.  Briefly, mice were anesthetized using isoflurane then placed on 
the ‘trap door’ platform.  To ensure accuracy and reproducibility of impact, a 1-meter vertical 
guide tube was aligned over the mouse’s head with the weight initially lowered to ensure the cap 
(diameter: 10mm) of 95-gram weight was centered directly on the midline between the ears. The 
weight was then raised and released, causing an impact to the top of the mouse’s cranium. Laser 
guides ensured precise alignment with the skull and video analysis ensured reproducible 
movement upon impact. After impact, the mouse was propelled through the trap door and 
underwent an 180° free rotation before landing supine on the collecting sponge cushion (10 cm) 
below. The mice were then moved to a carrying container and placed in a supine position to 
evaluate righting reflex response.  
     
The experiments consisted of two protocols for hit delivery: short inter-injury interval and long 
inter-injury interval. The ‘rmTBI-short’ protocol consisted of five rounds of weight drop impact 
to the top of the skull over a three-day period.  Hits were delivered as follows: Day 1: am hit, 6 
hr recovery, pm hit.  Day 2:  am hit, 6 hr recovery, pm hit.  Day 3: am hit.  For the ‘rmTBI-long’ 
protocol hits were delivered once every 3 days for a 15-day period, for a total of 5 hits with a 3-4 
 Acabchuk Dissertation 54 
day inter-injury interval.  The overall mortality rate for the rmTBI-short and rmTBI-long 
protocols was 37.5% and 0% respectively. Early termination (within 1 hr) due to motor 
impairments (i.e. paralysis) accounted for 20% of the mortality. The remaining mice died within 
4 minutes of impact (with death occurring in equal proportions across impacts 1-5).  Of the mice 
that did not survive the procedure, 25% had skull fracture and meningeal bleeding, 25%, had 
meningeal bleed without skull fracture, and the remaining 50% had no observable bleed or 
fracture [17].   
 
Separate groups of control mice were treated with time-matched doses of isoflurane anesthesia 
for each experimental protocol.  Following treatment, hit and control mice were either sacrificed 
immediately or kept in normal living conditions until time of sacrifice (2-weeks or 6-weeks post-
rmTBI).   
     
Immunohistochemistry (IHC).        
Mice were sacrificed by pentobarbital overdose and perfused with PBS followed by 4% 
paraformaldehyde. Brains were removed, photographed and inspected for gross morphological 
injury including cortical deformation and subdural or subarachnoid hemorrhage. Perfused brains 
were stored in 4% PFA at 4° C for 72 hours then shipped overnight in PBS from Wayne State 
University to the University of Connecticut.  Brains were embedded in agarose and sectioned 
coronally on a vibratome (VT-1000S; Leica) generating 50μm thick serial slices. Coronal tissue 
sections from 2mm anterior to 2.5mm posterior of Bregma were blocked in 10% horse serum 
(Invitrogen Life Technologies, Grand Island, NY, USA) in PBS/0.1% Triton X-100 for one hr. 
Tissue sections were immunostained overnight with the following primary antibodies in blocking 
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solution: rat anti-glial fibrillary acidic protein (GFAP, 1:250; Life Technologies, Grand Island, 
NY, USA), rabbit anti-aquaporin 4 (AQP4, 1:400; Sigma-Aldrich, St. Louis, MO, USA), mouse 
anti- S100 (1:500; Sigma), rabbit anti-IBA1 (1:500; Wako Chemicals, Richmond, VA, USA), 
rabbit anti-Myelin Basic Protein (MBP, 1:200, EMD Millipore, Billerica, MA, USA), mouse 
anti-SMI-32 (1:1000, BioLegend, San Diego, CA, USA), mouse anti-AT8 (1:200; Pierce 
Biotechnology, Waltham, MA). AT8 phosphorylated tau specificity was validated with mouse 
anti-PHF-1 (1:200) and mouse anti-CP13 (1:200), which were generous gifts from Dr. Peter 
Davies (Albert Einstein College of Medicine, Bronx, NY). After three washes in PBS, sections 
were incubated for 2 hr at room temperature with Alexa Fluor dye-conjugated secondary 
antibodies (1:500, Life Technologies) diluted in blocking solution. Tissue sections were then 
treated with DAPI nuclear stain for 5 min followed by three final PBS rinses. Tissue sections 
were mounted sequentially from anterior to posterior and coverslipped with aquapoly mount 
(Polysciences, Inc.; Warrington, PA). 
        
Image Analysis and Acquisition.  All images were acquired on a Zeiss Axio Imager M2 
microscope with ApoTome (Carl Zeiss MicroImaging, Inc., Thornwood, NY, USA), with a 
HAMAMATSU ORCA-R2 digital camera C10600.  Age matched controls for each time point of 
sacrifice and each hit protocol were processed and analyzed in tandem with treatment groups 
using IHC. The number of mice used for analysis in each protocol group and for each time point 
were as follows:  rmTBI-short protocol - immediate 3 hit/8 control; 2week 6 hit/6 control; 6week 
8 hit/5 control, and rmTBI-long protocol - immediate 4 hit/3 control; 2week 5 hit/4 control; 
6week 4 hit/4 control. Full tissue section image montages (generated every 300m from the 
anterior forebrain through the entire hippocampus) were used to inspect for alterations in GFAP, 
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IBA-1, AQP4, S100 or AT8.  SMI-32 and MBP were assessed with the same procedure in the 
2-week time point only. Upon scanning all brain regions for IHC alterations, observations of 
overt changes in GFAP and IBA-1 led to the lateral septum, corpus callosum and hippocampus 
being identified as regions of interest (ROI) for further analysis. High magnification images, 
taken from three consecutive brain slices (50m), were then collected for both ROIs using the 
same exposure settings for all hit and control brains for each group (time-point and protocol) for 
unbiased evaluation of histopathology. Septal montages were taken at 0.5 mm and hippocampus 
montages at -1.5 mm relative to Bregma.  Evaluation of microglial activation was performed in 
the lateral septum, corpus callosum, hippocampus, amygdala and cortex by examining 
morphological changes in microglia using the microglial marker IBA-1. An increase in the 
number of IBA-1+ cells with retracted processes and enlarged cell bodies were taken as an 
indication of microglial activation. Images were acquired of all consecutive slices that 
demonstrated microglial activation, further validating a defined ROI.  Comparison of mice across 
each group within a ROI was used for representative images.   
 
GFAP Quantification.   Immunoreactivity for GFAP was quantified using the mean pixel 
intensity in a given ROI using FIJI/ImageJ software (NIH, Bethesda, MD, USA). To ensure 
unbiased quantification and account for possible variability across groups, a uniform threshold 
value was obtained by averaging the automated threshold values of all control montages for each 
group (time-point and protocol). The group specific uniform threshold value was applied to all 
hit and control brains of a given group to obtain quantification values based on the average pixel 
density values across three consecutive tissue slices. Data acquisition was replicated under 
blinded conditions to ensure reproducibility and objective measurement technique. To determine 
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the extent and pattern of gliosis in the septal region, the dorsal lateral septum was quantified in 
three locations (mid lateral, peri-mid lateral septum, lateral septum), using the average values of 
the right and left hemisphere for the areas defined as ‘peri-mid’ and ‘lateral’.   GFAP 
quantification in the corpus callosum was derived from the average values of three locations 
within the corpus callosum: center, left and right hemispheres directly above the mid and lateral 
septal areas (starting at 0.5mm anterior to Bregma).  Hippocampal GFAP expression was 
measured using a single area directly adjacent to the midline at the beginning of the dentate 
gyrus, averaging the left and right hemispheres. In the cortex, GFAP quantification was 
performed in a single box. Quantifications were performed using a 200x200px/m area in all 
regions of the septum, corpus callosum and cortex and a 1350x600px/m area in the 
hippocampus.  
 
Lateral Ventricle Volume Analysis and Ependymal Lining Evaluation.  Lateral ventricle 
volumes were calculated based on the tracing protocol we developed and described previously 
[18].  Briefly, volumes were generated from serial coronal sections of the lateral ventricles, 
marked by S100+ ependymal cells that line the ventricles, traced in StereoInvestigator and then 
compiled in Neurolucida Explorer, generating 3-D volumetric renderings. Volume analysis was 
performed for all three time-points of both hit and control brains.  The ependymal lining of the 
lateral ventricles was examined for ependymal denudation (S100  and astrogliosis (AQP4 and 
GFAP) in all experimental groups.    
 
Statistical Analysis. To determine which factors significantly influenced changes in GFAP 
expression in each region of the septum, hippocampus and corpus callosum following rmTBI, 2-
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way full factorial ANOVAs were performed (group X protocol) for each region and for each 
post-injury time period using GraphPad Prism software (Table 1). Post-hoc (t-test) analysis was 
performed to test for differences between levels within each factor (testing for differences 
between hit and control for each region, protocol and time point). The p-values were adjusted 
using Bonferonni correction, to account for multiple testing (Table 2). All data are presented as 
the mean ± standard error of the mean (SEM). Statistical significance was determined by 
adjusted p values of <0.05.  
      
RESULTS: 
We employed a modified weight-drop method to deliver an impact to the top of the head that 
caused rapid acceleration and unrestrained 180° rotation of the mouse (Figure 1A-B). Mice 
showed no evidence of seizures, paralysis or behavioral abnormalities.  Our studies compared 
two protocols with differing inter-injury intervals, ‘rmTBI-short’ delivering 5 hits in 3 days, and 
‘rmTBI-long’ delivering 5 hits in 15 days (see timeline in Figure 1C). Average righting times 
following were 2-3 min following rmTBI-short, 1-2 min following rmTBI-long, with <1 min for 
both sets of control mice (details of righting times, see Table 3). Following rmTBI, mice were 
perfused at three post-injury time points, immediate, 2-weeks and 6-weeks, and the brains were 
sectioned from 2mm anterior to 2.5mm posterior to Bregma.  
 
Following exclusion of mice presenting signs of skull fracture and/or hemorrhage, gross 
examination revealed the brains from both protocols to be indistinguishable from control mice at 
all time-points following injury. No sign of morphological deformities, hemorrhaging, focal 
damage or contusion was observed on the surface of the brain (Figure 1D-E).   The absence of 
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injury to the cortical region directly below the site of impact indicates the mild nature of this 
protocol. In addition, there were no signs of diffuse axonal injury (SMI-32) or changes in myelin 
integrity (MBP) at the 2-week time point of both protocols (Figure 5). 
 
rmTBI causes acute microglial activation in the lateral septum and hippocampus.   
Neuroinflammation in response to brain injury can be acute and/or chronic [19]. To perform a 
regional analysis inspecting for areas of microglial activation, we examined changes in IBA-1 
expression throughout all brain regions. These studies revealed activated microglia, as indicated 
by an increase in the number of IBA-1-positive cells with retracted processes and enlarged cell 
bodies, accumulated in the dorsal lateral septum (Figure 2A) and hippocampus (Figure 2B) 
immediately following the rmTBI-short protocol. No other brain regions showed increased IBA-
1-positive cells. High magnification images of the lateral septum and hippocampus from the 
immediate time-point clearly illustrate morphological changes indicative of reactive microglia 
(Figure 2). IBA-1 expression was restored to baseline levels in both regions at the 2-week time-
point. With the rmTBI-long protocol, we did not observe microglial activation at any time-point. 
Since changes in activated microglial expression were restricted to the septal and hippocampal 
regions, with the cortex, amygdala and corpus callosum exhibiting only baseline IBA-1 levels 
following both protocols (data not shown), we concluded that the lateral septum and 
hippocampus are particularly vulnerable in rmTBI.   
 
Astroglial response is observed in the lateral septum, corpus callosum and hippocampus.   
Astrocytes help maintain homeostatic conditions in the central nervous system and display a 
complex and graded response to injury [20]. To perform a regional analysis inspecting for areas 
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of astrocytic response, we examined changes in GFAP expression throughout all brain regions. 
Similar to the microglial analysis, qualitative analysis revealed an astrocytic response in the 
septal and hippocampal regions. No changes in GFAP expression were observed in the cortex or 
amygdala at any time point (data not shown). In order to perform a quantitative analysis to 
compare GFAP intensity levels across experimental groups and protocols within each region, 
GFAP intensity was quantified in the hippocampus, corpus callosum and lateral septum, which 
was further sub-divided to provide a more comprehensive analysis of GFAP alterations in the 
septal region (Figure 3A). To compare GFAP expression across the protocols (short, long) at 
each given time point (immediate, 2-week, 6-week) within each region, we used 2-way full 
factorial ANOVAs on treatment (hit, control) X protocol (short, long) for each time point and 
region. This was followed by post-hoc (t-test) analysis with Bonferonni correction testing for 
differences between levels within each factor, allowing for comparison of hit and control groups 
processed in tandem with identical protocols and post-injury time points. The full list of F and P 
values for the ANOVAs are listed in Table 1 and the full list of adjusted t and P values are listed 
in Table 2.   
 
Immediately following the rmTBI-short protocol, there was a highly significant increase in 
GFAP expression in all septal regions (Mid LS t=20.7, Peri Mid LS t=14.78, Lat LS t=4.71) 
(Figure 3B, C), with both treatment and protocol acting as highly significant factors (significant 
factors are not displayed on graph, see Table 1).  The increase in GFAP staining remained 
significant in the septal region 2- and 6-weeks post-injury.  In contrast to the rmTBI-short 
protocol, the rmTBI-long protocol caused only an immediate increase in two of the septal 
regions (Mid LS t=4.452, Peri Mid LS t=3.505) with no persisting changes in the septal region 
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GFAP expression relative to control levels at 6-weeks post-injury. ANOVA results yielded a 
significant interaction between treatment and protocol in the mid LS (F=291.2) and peri-mid LS 
(F=51.53) at the immediate time point.  
 
The corpus callosum showed mixed results following rmTBI-short (Figure 3B, C), with a 
significant increase in GFAP expression at the immediate and 6-week time-point.  When the 
source of variation is taken into account, it appears the increase in GFAP at 6-weeks in the 
corpus callosum is specific to the short protocol.  No changes were observed in the corpus 
callosum following the rmTBI-long protocol at any time point.  High magnification images 
(Figure 3D, E) show changes in GFAP expression in the lateral septum and corpus callosum 
with increased GFAP+ processes appearing thicker and more numerous in the treatment 
conditions.   
 
In the hippocampus, we found an immediate astroglial response similar to that seen in the septal 
region (Figure 4B, C, left panel).  Specifically, in the rmTBI-short protocol, GFAP 
immunoreactivity was significantly increased over control levels at the immediate time-point 
(t=3.069) and also after 2-weeks (t=4.218), but GFAP levels were no longer significantly 
different at 6-weeks. Following the rmTBI-long protocol, there was no significant increase in 
GFAP intensity in the hippocampus at any time-point (Figure 4B, C, right panel). While an 
interaction between treatment and protocol was found in the hippocampus at 2-weeks, this was 
likely related to variability in control levels of GFAP expression. High magnification images of 
the dentate gyrus of the hippocampus (Figure 4 D) show changes in GFAP expression similar to 
what is found in the septal region following the rmTBI-short protocol.   
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To examine further the extent of the astrocytic reaction in the septum, hippocampus and corpus 
callosum, we investigated the calcium binding protein S100 and water channel protein AQP4. 
Astrocytes have been shown to increase expression levels of S100 and AQP4 during reactive 
gliosis [21-23]. No changes were observed in either S100 or AQP4 expression in any region 
examined, including the amygdala and cortex (Figure 5), suggesting that the astrocytic response 
observed in our studies was localized and mild in nature.   
 
Overall, results of GFAP quantification suggest that a shorter inter-injury interval causes a more 
significant astrocytic response in the lateral septum than a longer inter-injury interval with the 
same total number of hits. The hippocampus shows a similar pattern initially, displaying an 
immediate astrocytic response following the short protocol only. However in the hippocampus, 
GFAP levels return to baseline levels by 6-weeks.  The corpus callosum appears to have a slight 
astrocytic response following the rmTBI-short protocol only.   
 
No significant changes in phosphorylated tau in rmTBI protocol.  
We also examined changes in phosphorylated tau marker AT8. Accumulation of hyper-
phosphorylated tau is considered to be a hallmark feature of CTE [6, 24]. Using the AT8 
antibody that detects tau phosphorylation at Ser202/Thr205, our studies did not reveal significant 
changes in phosphorylated tau accumulation in any of the brain regions investigated (cortex, 
hippocampus, corpus callosum, lateral septum and amygdala) at any time point, following either 
protocol. AT8 was observed in the cortex at 6-weeks following rmTBI-short (Figure 5), which 
allowed for confirmation of positive antibody staining using additional phosphorylated tau 
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markers, but the level was not significantly different from controls.   
 
Ependymal lining and lateral ventricle volumes remain unchanged following rmTBI.   
As dilation of the lateral ventricles is a morphological feature of CTE and ependymal damage 
may contribute to ventricle expansion and/or impaired clearance of phosphorylated tau, we 
sought to determine if our rmTBI model resulted in lateral ventricle expansion.  To evaluate the 
integrity of the ependymal lining, we used S100 a marker for ependymal cells, and AQP4, an 
indicator of astrogliosis at the ventricle surface [25].  Our analysis confirmed the presence of an 
intact ependymal lining throughout the lateral ventricles following both the ‘short’ and ‘long’ 
protocols. GFAP expression was slightly elevated in selected regions of the ependymal lining, 
there was no overt indication of astrogliosis in the ventricle lining (Figure 5). In addition, when 
the volumes of the lateral ventricles were evaluated we did not detect any changes in volume at 
all 3 time-points compared to experimentally matched controls (data not shown).  
 
DISCUSSION: 
The objective of these studies was to perform an extensive regional investigation of forebrain 
and midbrain histological alterations in a biomechanically relevant model of rmTBI. The model 
we employed generated an impact that caused a very rapid and rotational acceleration of the 
head, which is fundamentally very similar to human concussive injury [15]. The absence of 
cortical damage and the observation of normal microglial and astroglial expression throughout 
the cortex confirmed the mild nature of the model.  rmTBI delivered in short inter-injury 
intervals (rmTBI-short) led to an immediate increase in IBA-1 and GFAP expression signifying 
acute microglial activation and astrocytic response in the dorsolateral septum and hippocampus. 
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The microglial response was resolved throughout the brain by 2-weeks post-injury.   Six-weeks 
post-injury, the astrocytic response persisted in the lateral septum, but was resolved in the 
hippocampus. The corpus callosum appeared to have a mild astrocytic response present initially 
and six-weeks post-injury. When the inter-injury interval was lengthened (rmTBI-long protocol), 
the effect was diminished.  We found an immediate astrocytic response in the lateral septum 
only, but no microglial activation was found in any brain region examined.  Six weeks following 
the rmTBI-long protocol, GFAP expression in the septum returned to baseline levels (Figure 6). 
 
The purpose of comparing two rmTBI protocols with different inter-injury intervals was to 
provide insight into repetitive injury scenarios where repeated concussive and/or subconcussive 
injuries occur at different frequencies. The protocol comparison of 5 hits over 3 days versus 5 
hits over 15 days demonstrates that the inter-interval periods (time between hits) are a critical 
factor in the extent of histological response. Currently, there are no clinical tests capable of 
confirming the presence or absence of cellular changes following mTBI in humans, increasing 
the difficulty of making concussion diagnosis or developing a treatment regimen [8]. Our results 
demonstrate that a shorter inter-injury interval can lead to a more significant cellular response in 
the form of acute microglial activation and prolonged astrogliosis in select regions of the brain.  
These results are in accordance with other studies that found that the brain is subject to 
exponential damage when hits are delivered in quick succession, within 24 hours [26]. The 
finding of microglial activation immediately following the rmTBI-short protocol, but not 
following the rmTBI-long protocol indicates microglial priming may play a role in the 
exaggerated microglial response found following the rmTBI-short protocol.  Whereas the longer 
48-72 hour inter-injury interval in the rmTBI-long protocol may be sufficient time to return to 
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homeostatic neuroimmune conditions prior to a subsequent hit, at least in mice. It is also possible 
that other factors contributed to the amplified microglial activation found with the rmTBI-short 
protocol, such as increased intracranial pressure or microbleeds that were too small to identify. 
While further investigation of the M1/M2 phenotype would help elucidate the nature of the 
microglial reaction, the changes observed in our model were temporary (resolved by 2-weeks) 
and region specific, suggesting the reaction is not replicating the long-term neuroinflammatory 
response found in human CTE [27, 28].  
 
The increase in GFAP expression levels found in the dorsolateral septum and hippocampus in 
our studies is indicative of an astrocytic response, but would not be considered a glial scar. 
GFAP is known to impart mechanical strength in astrocytes, and astrocytes increase the 
intermediate filament GFAP in response to mechanical stress [29].  Our results suggest the 
astrocytic response observed in our studies is a reaction to impact and rotational forces imparting 
higher levels of mechanical stress in these two regions.   
To determine the degree to which the current protocols generated a CTE-like phenotype, we 
tested for phosphorylated tau accumulation and ventricular dilation, neither of which were found 
in our studies. Activation of a chronic immune response has been linked to progressive 
neurodegeneration and phosphorylated tau accumulation [30, 31]. In our studies, we did not see 
signs of diffuse axonal injury and the microglial response was resolved within 2-weeks even 
under the more severe condition (rmTBI-short), which suggests the current protocols are unlikely 
to generate phosphorylated tau accumulation. We also did not observe changes in ventricle size 
in our studies; however, this may also be due to a variety of factors (i.e., the disparity of brain 
volume to ventricle volume ratio between humans and mice, the location of the impact, lack of 
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damage to ependymal lining). Our selection of CD1 mice for the current study was based on 
their consistent ventricle volume; C57 mice can spontaneously develop hydrocephalus and 
therefore were not appropriate for our studies. While mortality, attributed to central respiratory 
depression [32], skull fractures and hemorrhaging necessitated the exclusion of several subjects 
from the rmTBI-short protocol, our findings of a focal response in the septum and hippocampus 
were consistent in the experimental group of mice that showed no signs of bleeding, skull 
fracture or cortical damage. Our analysis did not reveal signs of diffuse axonal injury or myelin 
damage in the corpus callosum at the 2-week post-injury time point. 
Behavioral and functional testing in mice exposed to similar mTBI models has revealed impaired 
cognitive skills (Morris water maze), impaired motor skills (wire grip and rotarod), anxiety-like 
behavior (open field test), acute sleep disturbances and disturbances to species-specific 
behaviors, such as nesting [15, 33-35], and changes in hippocampal synaptic plasticity [9, 28]. 
The current study may generate similar behavioral and functional deficits due to the patterns of 
cellular damage identified in the current model. However, it is also possible that the impact of 
persistent, but subtle, astroglial responses in the lateral septum and hippocampus may necessitate 
sensitive physiological recordings in order to detect functional changes within the brain.  
Importantly, our results show that both the lateral septum and hippocampus have a heightened 
cellular response in the form of microglial and astroglial activation following rmTBI. Similar 
neuroinflammatory response has been identified in the hippocampus of retired NFL players with 
a new non-invasive, in vivo radiolabeling technique using PET and MRI imaging [36]. Both 
structures are similarly located along the neuraxis directly below the corpus callosum and 
between the lateral ventricles.  An underlying feature of the two regions is that they are found 
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where different tissue types and densities interface (corpus callosum-dorsolateral septum, corpus 
callosum-hippocampus). These regions may be more susceptible to injury due to anisotropic 
shear force generated by mechanically induced tissue deformation. Our results show the most 
prominent cellular response is in the lateral septum and hippocampus, directly below the corpus 
callosum, which is consistent with results from computer generated modeling that predict the 
highest rate of strain to occur in the corpus callosum [14]. It is important to note that structural 
damage to the septal region may be linked to fenestrated and/or cavum septum pellucidum, 
which is a common feature of CTE [4].  A recent MRI study shows the prevalence, grade and 
length of cavum septum pellucidum are higher in retired American pro-football players 
compared to memory clinic controls [37].  Functionally, the lateral septum is part of the septo-
hippocampal axis and limbic system, which modulates memory and emotions, and the lateral 
septum has been implicated in the neuronal circuitry of anxiety and fear [38, 39]. Therefore, it is 
possible that the microglial and astroglial responses found in the current studies may impact 
these networks.  
CONCLUSION: 
Our studies used two mouse models of rmTBI that incorporated acceleration, deceleration and 
rotational forces to investigate regional vulnerability.  We found that the inter-injury interval 
plays a significant role in determining the extent of damage, whereby an immediate activation of 
microglia and a prolonged astrocytic response arose only when the hits occurred within a 16-
hour timeframe (rmTBI-short).  Our results highlight the lateral septum, corpus callosum and 
hippocampus as regions of particular interest following rmTBI. Damage to the septo-
hippocampal axis from rmTBI may contribute to clinical rmTBI symptomology, including 
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anxiety and memory problems, and fenestrated septum pellucidum, which is a notable feature of 
CTE.  
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FIGURES AND LEGENDS 
Figure 1 
 
Figure 1:  Experimental Overview (A) A modified weight drop method delivers impact to the 
top of the head, propelling the mouse through a trap door stage onto a collecting sponge, 
modeling rapid acceleration and rotational forces found in concussion. (B) Illustration showing 
location of hits, direction of rotation (red arrows) and regions of the brain investigated (blue 
lines).  (C) Timeline of experimental procedures that vary in their inter-injury interval: 5 hits in 3 
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days (rmTBI-short), 5 hits in 15 days (rmTBI-long).  Sacrifice and collection of brain tissue 
samples occurred at immediate, 2-week and 6-week post-injury time-points.  (D) No significant 
gross damage is observed following impact procedures. (E) Immunohistochemical analysis of 
DAPI nuclear staining at the immediate time point for rmTBI-short and control brains 
demonstrates rmTBI brains are indistinguishable from controls in cortical regions, including 
regions directly below impact (E), thus modeling rmTBI. (Scale bars, 1000m) 
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Figure 2 
 
 
Figure 2:  Isolated microglial activation (IBA-1) is present in lateral septum and 
hippocampus immediately following rmTBI-short.  (A-B) For orientation, a blue dotted line 
was drawn through the center of the corpus callosum.  Left panels show increased IBA-1 
expression localized to the dorsal lateral septum and hippocampus immediately following the 
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rmTBI-short protocol. Higher magnification images of the septum and hippocampus show 
morphological changes indicative of reactive microglia immediately following rmTBI-short, but 
not rmTBI-long. No changes in microglial activation were observed at the 2-week and 6-week 
time-point of either protocol. (Small scale bars, 500m; large scale bars (magnified images), 
100m). 
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Figure 3 
 
Figure 3: The lateral septum shows immediate and sustained increases in GFAP 
immunoreactivity following both protocols. (A) Atlas image illustrates regions used for GFAP 
quantification (200 X 200 m boxes). (B-C) Graphs of GFAP intensity levels were generated 
using threshold analysis and are shown with corresponding representative images. 2-way 
factorial ANOVA (treatment X protocol) performed on each region and post-injury time period 
shows significant interactions occurring in the mid and peri-mid lateral septal regions at the 
immediate time point (red *). Post-hoc (t-test) analysis with Bonferonni correction was used to 
compare rmTBI treatment to respective control groups within each time point and region. All 
three regions of the dorsal lateral septum show immediate and sustained increases in GFAP in 
the rmTBI-short protocol (C-left panels). In the rmTBI-long protocol (C-right panels), increased 
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GFAP is resolved in all septal regions at 2 weeks. The corpus callosum shows a significant 
increase in GFAP immediately and 6-weeks following the rmTBI-short protocol. (D-E) 
Representative high magnification images in peri-mid lateral septum and corpus callosum show 
changes in GFAP expression immediately and 6 weeks following rmTBI-short compared to 
control. Data are expressed as mean ± SEM (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001). 
(Scale bars: 300m (C), 40m (D-E)).  
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Figure 4 
 
Figure 4: Hippocampus shows significant increases in GFAP immunoreactivity 
immediately and 2 weeks following rmTBI-short protocol. (A) Boxed region in atlas image is 
magnified on right to show 1350 X 600m areas used for GFAP quantification. (B-C) Graph of 
GFAP quantification using threshold analysis and corresponding representative images shows 
GFAP expression (green) and DAPI (blue). 2-way factorial ANOVA (treatment X protocol) 
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showed a significant interaction between treatment and protocol 2 weeks post-injury (red *). Post 
hoc (t-test) analysis using Bonferonni correction to test for differences between levels within 
each factor shows significantly increased GFAP in the hippocampus immediately and 2 weeks 
following the rmTBI-short protocol, with overall GFAP expression levels returning to baseline at 
6 weeks.  No changes in GFAP expression levels occurred following the rmTBI-long protocol in 
the hippocampus. (D) Representative high magnification images in dentate gyrus show changes 
in GFAP expression immediately and 6 weeks following rmTBI-short compared to control. Data 
are expressed as mean ± SEM (* p<0.05, ** p<0.01, *** p<0.001). (Scale bars: 500m (C), 
50m (D)). 
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Figure 5 
 
Figure 5.  Representative images of null findings.  (A) Levels of phosphorylated tau (AT8, 
white arrow) in the cortex and hippocampus following the rmTBI-short protocol (observed at 6-
week time point) were not significantly different from controls.  GFAP and AQP4 are present 
along the perimeter of the AT8 staining, suggesting astrocytic endfeet surround the 
phosphorylated tau accumulation and/or the accumulation is associated with blood vessels lined 
by astrocytic endfeet.  (B) The ependymal lining of the lateral ventricle remains intact at all time 
points and in all protocols of rmTBI, as demarked by S100 staining of the ependyma.  Elevated 
GFAP is noted in the dorsal wall of the lateral ventricle immediately following the rmTBI-short 
protocol.  (C-D) No signs of axonal damage (indicated by increased levels of SMI-32) in the 
cortex or corpus callosum and no observable changes in myelination (MBP) in the corpus 
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callosum 2-weeks following either rmTBI protocol is observed.  Representative images are all 
from the rmTBI-short protocol and located -1.5mm and 0.5mm relative to Bregma, respectively.  
(Scale bars: 50m (A), 100m (B), 200m (C), 200m (D)). 
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Figure 6 
 
 
 
Figure 6. Overview of results.  (A) Following a rotational model of rmTBI, the astrocytic and 
microglial response appears to be initially localized to the lateral septum and hippocampus, with 
a moderate astrocytic response occurring in the corpus callosum. Comparison of the two hit 
protocols demonstrates the enhanced histological response in select regions when the hits are 
delivered in rapid succession. (B) Table shows summary of experimental findings including 
positive and null results. 
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Table 1 
 
 
Table 1.  ANOVA Results for GFAP quantification.  2-way full factorial ANOVA (treatment 
X protocol) for each ROI and post-injury time point revealed treatment (hit, control) as a highly 
significant factor at the immediate time point in all septal regions (Mid LS F=99.98, Peri Mid LS 
F=154.4, Lat LS F=23.08) with treatment persisting as a significant factor at 6-wks in the mid 
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(F=6.52) and peri-mid LS (F=5.17). Treatment was also a significant factor immediately in the 
corpus callosum (F=10.8) and hippocampus (F=11.75).  Protocol was a significant factor at the 
immediate time point in all septal regions (Mid LS F=108.2, Peri Mid LS F=76.71, Lat LS 
F=7.677) with and the corpus callosum (F=12.34), and persisted as a significant factor in the mid 
LS (F=4.913) and hippocampus (F=5.047) at the 6-wk time point. Significant interactions are 
displayed in Figures 3 and 4.   
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Table 2.   
 
 
Table 2. Adjusted t-test values for GFAP Quantification.  Listing of t-test values with 
Bonferonni correction show differences in treatment (hit, control) for each ROI, protocol and 
time point.  Significant P-values are displayed in Figures 3 and 4. 
 Acabchuk Dissertation 83 
Table 3 
 
 
 
 
 
Table 3 with associated Graph.  Average righting times following rmTBI and sham 
treatment (isoflurane only) for both protocols. (Note: rmTBI data includes righting times from 
subjects later excluded due to mortality, skull fracture, hemorrhage, etc.). 
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Chapter 4:  Tissue preparation and three-dimensional imaging of 
intact biological structures 
 
 
Introduction 
 
Biological structures within the brain are inherently three-dimensional (3D); however, because of 
limitations in antibody penetration and light scatter that obscures deep imaging, researchers are 
often resigned to sectioning through structures and reconstructing the images (Richardson, 
Lichtman 2015). Sectioning and reconstructing structures can be a lengthy and cumbersome 
process.  For many research applications, it would be ideal to image whole structures rather than 
just the parts.   
Rapidly evolving tissue clearing techniques have recently been developed that render a 
biological tissue optically clear by removing lipids and/or introducing a medium that has the 
same refractive index as the cells  (Albanese, Chung 2016). Each protocol comes with its own 
advantages and disadvantages; disadvantages may include tissue shrinkage, expansion, 
quenching of protein fluorescence, changes in sample characteristic (rendering the tissue stiff, 
spongy, or fragile), cost and clearing times ranging from days to months  (Costantini, Ghobril et 
al. 2015). Most tissue clearing techniques are designed to either preserve endogenous fluorescent 
reporter molecules or to be compatible with immunohistochemistry (IHC).  Upon evaluating the 
various tissue clearing protocols, we selected the method for immunolabeling-enabled 3D 
imaging of solvent-cleared organs termed iDISCO for our initial investigations, which was 
developed by researchers at Rockefeller University, to optimize IHC with the tissue clearing 
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process  (Renier, Wu et al. 2014).  iDISCO permits whole-mount immunolabeling with volume 
imaging of cleared samples without requiring specialized equipment.  Additional studies are also 
currently underway in our lab to investigate other clearing protocols including CUBIC (Clear, 
Unobstructed Brain/Body Imaging Cocktails and Computational analysis) (Susaki, Tainaka et al. 
2014) and PACT (passive clarity technique), a protocol for passive tissue clearing and 
immunostaining of intact organs using RIMS (refractive index matching solution), a mounting 
media for imaging thick tissue  (Yang, Treweek et al. 2014, Treweek, Chan et al. 2015).  A 
collaboration with Quorum Technologies Inc. has also been established to test our tissue samples 
using CLARITY-based techniques (Chung, Wallace et al. 2013). Once a clearing technique is 
rendered successful in the hands of our lab, it can be applied to a variety of research questions 
including those related to aging, brain injury and neurodegenerative disease. 
 
Along with tissue clearing, advancements in microscopy are facilitating 3D imaging of intact 
biological structures deep within the brain.  Applications of these techniques will be particularly 
useful for visualizing structures that span beyond single imaging planes such as investigating 
below the surface of periventricular gliosis and visualizing septal and hippocampal changes 
following repeated mild traumatic brain injury (rmTBI). 3D imaging of cleared, immunolabeled 
tissue can be applied to injury models to investigate the astrocytic and microglial reaction in scar 
formation within the brain in response to injury.  
The goal of the current study is to evaluate tissue preparation and imaging techniques for 
obtaining high quality 3D images of intact biological structures to enhance future investigations 
evaluating gliotic changes following brain injury, or in aging or disease. I used the hippocampus 
and rostral migrating stream (RMS) in my analysis because of the unique cellular organization of 
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these two regions that includes dense patterning of astrocytes and neuroblasts, which will allow 
testing of immunolabels we plan to use in future investigations of glial scar formation.  By 
comparing different tissue preparation protocols with 3D optimized whole mount tissue 
preparation, the study aimed to generate baseline images of successful antibody penetration in 
thick tissue sections. Results from this study will allow for further comprehensive investigation 
of changes that occur to cell morphology and tissue structure in injury and disease models.   
 
Methods 
 
Animals 
Male and female CD-1 mice (Charles River, Wilmington, MA, USA), age 8-12 wks, were used 
for all experiments.  Animal procedures were approved by the University of Connecticut IACUC 
and conformed to NIH guidelines.  
Tissue clearing and immunostaining with iDISCO protocol 
To clear and stain whole tissue sections, we performed the iDISCO protocol as described in 
Renier et. al., 2014. Briefly, mice were perfused and brains were fixed with paraformaldehyde, 
then intact brains were dehydrated with methanol, bleached with H2O2, rehydrated, and then 
placed in blocking solution for 3 days at 37.  Tissue was immunostained with the following 
antibodies:  Goat anti Doublecortin (1:200) (Santa Cruz, TX), Rabbit anti IBA1 (1:500) (Wako 
Chemicals, VA), Rat anti GFAP  (1:250) (Life Technologies, CA).  As some of these antibodies 
were not previously validated with the iDISCO protocol, we first performed antibody validation 
steps to ensure methanol compatibility, which was successful for all antibodies.  Incubation time 
was 3 days for both primary and secondary antibodies.  Following immunostaining, tissue was 
 Acabchuk Dissertation 87 
dehydrated in tetrahydrofuran (THF) (Sigma), lipid solubilisation was performed using 
dichloromethane (Sigma) then tissue sections were placed in dibenzyl ether (DBE) (Sigma) for 
final clearing and to match refraction index to optimize imaging.  The specimen was stored in 
DBE for 1 month then mounted using a 3mm 3D printed chamber containing DBE affixed to a 
slide using Kwik-sil epoxy (VWR).   The chamber was created using a 3D printer (print 
company:  http://www.goactgroup.com/, printing instructions: https://idisco.info/idisco-
protocol/) using  Visijet M3 Clear resin, which is resistant to DBE.   
Whole Mount Immunostaining  
Whole mount tissue preparation was performed as previously described (Shook et al, 2014) with 
the following modifications:  Tissue sections were placed in block (10% horse serum, 0.2% 
Triton) overnight and primary/secondary incubations were set to 3d. This timeframe was based 
on initial pilot testing of 1-4 days incubation periods, which demonstrated that a minimum of 3 
days was required for both primary and secondary antibodies for successful labeling beyond the 
surface of the tissue.  Primary antibodies were used at double their normal concentration: Rat 
anti-GFAP (1:125), Rabbit anti-IBA-1 (1:250), Guinea Pig anti-Doublecortin (DCX) (1:500) 
(Millipore, MA), Rabbit anti-AQP4 (1:100) (Sigma-Aldrich, MO). Alexa Fluor dye-conjugated 
secondary antibodies (Life Technologies) diluted in blocking solution: Donkey anti Rat 488 
(1:500), Donkey anti Rabbit 546 (1:500), Donkey anti Guinea Pig 647 (1:100).  All specimens 
were incubated in DAPI at R/T for 25 min prior to final rinses and mounting.  Tissue was 
mounted on slide using a generous amount of Aqua-Poly Mount to ensure even placement of 
coverslip.      
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Image Acquisition and Processing 
All images were acquired on a Leica TCS SP8 Confocal Microscope.  3D image processing was 
performed using Leica LAS X 3D Visualization Package.  Linear z-stack compensation was 
required to enhance gain and laser power for imaging beyond a depth of approximately 80 m.   
Results 
Modified whole mount processing yields antibody penetration up to 120 m. 
In order to pave the way for future studies that plan to use new tissue clearing techniques to 
facilitate 3D imaging, I first sought out to determine the maximum capacity of antibody 
penetration for antibodies of interest without the assistance of a tissue clearing method. The two 
regions of interest selected for these studies were the hippocampus and RMS.  These regions are 
conducive to 3D investigations because both the hippocampus and RMS are comprised of a 
unique cellular organization of astrocytes and neuroblasts, which can be useful for future studies 
investigating brain injury and glial scar formation.  The hippocampus is of particular interest 
because we found astrocytes upregulate GFAP in this region following rmTBI (see Chapter 3).  
As the central focus of my studies is on gliotic changes that occur in aging and injury, the 
antibodies tested for 3D imaging include GFAP, IBA-1, DCX and AQP4. Astrocytes increase the 
intermediate filament GFAP in response to mechanical stress and injury (Cullen 2007).  IBA-1 is 
important for identifying changes in neuroimmune activation following injury by allowing 
visualization of changes in microglial morphology, and DCX is used to label neuroblasts, 
another primary cell type and distinguishing feature in both of these regions of interest.  AQP4 is 
important in evaluating injury because we found an upregulation of AQP4 in areas of 
periventricular gliosis in both human and mouse tissue (Chapter 2).    
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Approximately 500-1000m thick sections were hand-cut with straight razor from young adult 
mice, using sagittal sections for the RMS, as this migratory pathway is oriented anterior to 
posterior within the brain (Figure 1A), and using coronal sections for the dentate gyrus of the 
hippocampus (Figure 1B), as this structure is most easily isolated in the frontal plane.  After 
several rounds of testing protocol optimization, I found a 3-day incubation period in primary and 
secondary antibodies using 0.2% Triton in the blocking solution to assist tissue permeability 
allowed antibody penetration up to 120m in depth. Representative 3D images using a 
hippocampal section display successful antibody penetration for DAPI and GFAP (Figure 2 A-
B); however, IBA-1 staining appeared slightly globular and did not fully match anticipated 
microglial morphology. Sample images from an RMS tissue section demonstrate that in addition 
to GFAP, DCX labeling is also successful up to 100m in depth, allowing for 3D visualization 
of migrating chains of neuroblasts and surrounding astrocytes (Figure 3).  AQP4 also penetrated 
to the same depth (100m) in the RMS tissue samples, but IBA-1 staining in the RMS has 
similar issues to the hippocampal sections (data not shown). For all successful immunolabels 
(GFAP, DAPI and DCX) in both the hippocampus and RMS samples, signal reduction was 
apparent from 80m +, which was corrected for by using the Leica TCS SP8 z-compensation 
tool to enhance gain and laser intensity when acquiring deeper sections of the image.  
 
Initial attempts using iDISCO tissue clearing protocol does not improve 3D imaging 
Our next goal was to determine if tissue clearing can enhance 3D imaging to a greater depth 
beyond the 120m thickness achieved with the modified whole mount processing using the same 
antibodies of interest.  The iDISCO protocol was selected for the tissue clearing method because 
it does not require expensive equipment and is optimized for immunostaining (while most other 
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clearing protocols also work with immunostaining, they are optimized for maintaining 
endogenous fluorescence).  We tested the iDISCO tissue clearing and staining protocol using 
sections of mouse brain cut similarly to the 500-1000m thick whole mount sections (Figure 1) 
and also using larger sections up to a half hemisphere sliced coronally at Bregma (Figure 4A).  
All tissue sections were successfully cleared following the 16-day process culminating in 
incubation in DBE – some tissue shrinkage occurred (Figure 4B).  Tissue samples were mounted 
on a slide using a coverslip affixed to the 3D printed imaging chamber containing the refractive 
index matching solution DBE then imaged on the SP8 confocal microscope. Surprisingly, we 
found antibody staining limited only to a depth of 65 m for GFAP and IBA-1 (Figure 4C), 
which was further reduced only days later.     
Discussion  
In our pilot studies, the modified whole mount method without tissue clearing yielded superior 
3D volume imaging compared to tissue prepared with the iDISCO tissue clearing protocol.  Our 
whole mount optimization process successfully produced volume images of the hippocampus 
and RMS up to a depth of 120m for GFAP, DCX and DAPI. The 3D images were aided by z-
stack compensation to enhance illumination of AB at levels beyond 80m below the surface.  
The z-compensation tool is linear, while antibody intensity tends to remain steady then taper off 
exponentially.  Thus, it is important to create multiple set-points when setting up the z-
compensation. 3D imaging of the RMS and hippocampus demonstrate distributions of astrocytes, 
neuroblasts and nuclei in the 3D plane, which can enhance future studies that investigate regional 
and temporal changes that occur following repeated brain injury. Advantages of the modified 
whole mount method include no tissue shrinkage, simple and relatively brief (8d) staining and 
mounting procedures.  Disadvantages include limited AB diffusion. Future tests can be 
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performed to determine if altering the thickness of the tissue section can enhance AB penetration 
beyond what was observed in the current studies.  Trouble shooting strategies for IBA-1, which 
was not successful using the modified whole mount method, include testing alternative 
concentrations and using tissue slices of progressive widths. 
 
Results of the iDISCO protocol were inconclusive; tissue clearing appeared successful, however, 
AB penetration appeared limited to only 65m, which deteriorated days later.  This rapid 
quenching of fluorescent signal may indicate a problem with the mounting setup, which had 
small air bubbles trapped inside. The iDISCO protocol requires the tissue to be mounted in the 
refraction index matching solution DBE, which is highly corrosive thus requiring a specialized 
mounting chamber.  It is possible the air bubbles trapped in the imaging chamber caused the 
tissue to oxidize, contributing to the antibody deterioration. Our results also revealed prominent 
tissue shrinkage using the iDISCO protocol, which could affect studies aimed to assess changes 
in tissue structure.  Further studies are required to properly assess the potential depth of staining 
using the iDISCO protocol.  
 
Regardless of the tissue clearing protocol selected, future studies using thick tissue samples may 
benefit from using the new method developed at MIT called SWITCH  (Murray, Cho et al. 
2015), a system-wide control of interaction time and kinetics of chemicals.  SWITCH allows for 
uniform tissue processing by switching reactions on and off. To facilitate even antibody diffusion 
and labeling, SWITCH uses the detergent sodium dodecyl sulfate (SDS) to inhibit antibody 
binding during diffusion. A major benefit of SWITCH is that it allows for multiple iterations of 
antibody staining on the same tissue specimen.  This can be extremely useful for performing 
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comprehensive characterization and analysis of large intact tissue samples. In our rmTBI studies 
described in Chapter 3, we used two sets of antibody combinations alternating every 50m 
section, which still did not allow us to test all of the possible histological changes that might 
occur following concussive injury.  Future rmTBI studies using SWITCH for multiple rounds of 
immunostaining will enable investigation of gliosis, microglial activation, changes in AQP4 
expression, myelin and axonal damage and more within the same tissue section.  SWITCH 
multiplex labeling will be especially important when using thick tissue sections for 3D imaging, 
because alternating antibody combinations would no longer be an option. SWITCH fixation 
strategies that work by altering pH to enable even fixation would also useful for future studies 
using human tissue such as those discussed in Chapter 2.   
 
Conclusion 
While the results of our initial testing of the iDISCO protocol were inconclusive, the modified 
whole mount procedure and resulting 3D images established in this work provide a useful 
foundation for assessing tissue clearing protocols aimed to optimize 3D imaging of thick tissue 
samples.  3D visualization and analysis will facilitate investigation of cellular changes that occur 
in aging, injury and disease that include damage to the ependymal lining, astrocytic and 
microglial reactions in rmTBI, and changes in cell migration. Future studies utilizing rapidly 
evolving tissue clearing techniques and multiplexed labeling technology will enhance analyses of 
intact brain structures such as the hippocampus. 
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Figures 
 
Figure 1 
 
 
Figure 1.  Area of hand-cut dissection of RMS and Hippocampus.  Tissue sections (red 
rectangles) were cut using straight razor hand dissection for the RMS (A) and hippocampus (B) 
whole mount preparations.  Thickness for both sections was approximately 0.5mm.     
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Figure 2 
 
 
 
 
Figure 2.  Sample 3D images of hippocampus.  Antibody penetration and visualization was 
successful up to 120m below the surface for nuclei (DAPI, blue) and astrocytes (GFAP, green), 
allowing 3D visualization of the dentate gyrus of the hippocampus.  Microglial labeling (IBA-1, 
red) was visible in the sample, but did not appear as robust labeling.  
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Figure 3 
 
Figure 3.  Sample 3D images of the RMS.   Astrocyte (GFAP) and neuroblast (DCX) labeling 
was successful up to 100m below the surface of the tissue, allowing 3D visualization of 
migrating neuroblasts and surrounding astrocytes within the RMS.   
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Figure 4 
 
 
Figure 4.  iDISCO Tissue Clearing Protocol and Sample 3D Images.  (A) Initial dissection of 
adult mouse left anterior forebrain (*). (B) Tissue segment from (A) after further dissection of 
cortical tissue shown before (left) and after (right) iDISCO clearing protocol.  (C) Sample 3D (z-
stack) images of astrocytes (GFAP, green) and microglia (IBA-1, red) in cleared anterior 
forebrain tissue.  Images were acquired on Confocal Laser Scanning Platform Leica TCS 8 using 
Leica 3D Visualization Module, which can be further analyzed with Leica Analysis and 
Quantification Modules to obtain measurements of 3D structures.   
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Chapter 5:  Conclusions 
 
 
 
Summary of Chapters 2, 3 and 4 
 
In Chapter 2, I presented our work investigating the link between ventriculomegaly and 
ependymal gliosis. Age-associated ventriculomegaly is typically attributed to neurodegeneration; 
however, additional factors might initiate or contribute to progressive ventricular expansion. By 
directly linking postmortem human MRI sequences with histological features of periventricular 
tissue, we showed that substantial areas of lateral ventricle surface gliosis were associated with 
ventriculomegaly. To examine whether loss of ependymal cell coverage resulting in ventricle 
surface glial scarring can lead directly to ventricle enlargement independent of any other injury 
or degenerative loss, we modeled in mice the glial scarring found along the lateral ventricle 
surface in aged humans. Neuraminidase, which cleaves glycosidic linkages of apical adherens 
junction proteins, was administered intracerebroventricularly to denude areas of ependymal cells. 
Substantial ependymal cell loss resulted in reactive gliosis rather than stem cell-mediated 
regenerative repair of the ventricle lining, and the gliotic regions showed morphologic and 
phenotypic characteristics similar to those found in aged humans. Elevated levels of aquaporin-4, 
indicative of edema, observed in regions of periventricular gliosis in human tissue were also 
replicated in our mouse model. 3D modeling together with volume measurements revealed that 
mice with ventricle surface scarring developed expanded ventricles, independent of 
neurodegeneration. Through a comprehensive, comparative analysis of the lateral ventricles and 
associated periventricular tissue in aged human and mouse, followed by modeling of surface 
gliosis in mice, we have demonstrated a direct link between lateral ventricle surface gliosis and 
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ventricle enlargement. These studies highlight the importance of maintaining an intact 
ependymal cell lining throughout aging.  
 
The studies presented in Chapter 3 used a modified weight drop model of rmTBI to perform an 
extensive regional investigation of histological alterations following repeated concussions. The 
model generated mild injury replicating the acceleration and rotational forces of mTBI, allowing 
for repeated applications.  We compared two protocols that vary inter-injury interval:  rmTBI-
short delivered 5 hits in 3 days, rmTBI-long delivered 5 hits in 15 days. Investigation of cellular 
changes throughout brain regions from 2mm anterior to 2.5mm posterior to Bregma 
demonstrated immediate microglial activation and increased GFAP intensity following the 
rmTBI-short protocol in the dorsal lateral septum and hippocampus.  6-weeks following the 
rmTBI-short protocol, microglial activation was resolved in all regions, while the astrocytic 
response persisted in the lateral septum. The corpus callosum also had a mild astrocytic response 
immediately and 6-weeks following the rmTBI-short protocol. Comparison of the two hit 
protocols demonstrated an enhanced histological response when the hits were delivered in rapid 
succession.  Null findings included no cellular changes in the cortex or amygdala, no p-tau 
accumulation, no changes in ventricle volume (ependymal lining integrity remains intact), and no 
findings of diffuse axonal injury or myelin alterations (assessed 2-weeks post injury).   In 
summary, damage in the septal region and hippocampus, both located directly below the corpus 
callosum and between the lateral ventricles, may be linked to intensified shear force at junctions 
between gray and white matter.  The lateral septum is known to modulate memory and emotions, 
especially anxiety and fear. Our findings suggest damage to the septo-hippocampal axis from 
rmTBI may be linked to clinical rmTBI symptomology, including anxiety and memory problems 
and fenestrated septum pellucidum, which is a notable feature of CTE. 
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The goal of the studies presented in Chapter 4 was to evaluate tissue preparation and imaging 
techniques for obtaining high quality 3D images of intact biological structures to enhance future 
investigations evaluating histological changes in aging, brain trauma or disease. Specifically, the 
studies developed a modified whole mount processing technique to optimize penetration of 
immunomarkers useful for evaluating gliotic changes in thick tissue sections, resulting in 3D 
images up to 120m thick.  These baseline 3D images were then compared against the results 
obtained using the iDISCO tissue clearing protocol.  While my initial attempts of processing 
tissue using iDISCO did not yield successful results, suggestions for troubleshooting and further 
studies using the new multiplex processing technique SWITCH are presented to pave the way for 
future work using 3D visualization.  The sample 3D images obtained using the modified whole 
mount processing that yielded successful antibody penetration of GFAP, DAPI and Doublecortin 
up to 120m will provide future researchers with comparisons to ensure the clearing protocol of 
choice enhances imaging beyond the baseline values provided here.   
 
Together, these studies emphasize the ventricular system and its ependymal lining as important 
central nervous system features that should be considered in the pursuit of understanding 
neurophysiological mechanisms underlying changes that occur to the brain in aging, head trauma 
and neurodegenerative disease.   
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Discussion of gliotic activation, associated alterations in mechanical properties and 
ventriculomegaly 
Astrocytic and microglial activation 
A unifying theme of the studies presented in Chapters 2, 3 and 4 is immunohistochemical 
analysis of astrocytic and microglial activation in aging and brain injury.  The functions of 
resting astrocytes and microglia include supporting neuronal function and actively promoting a 
healthy CSN environment.  Following injury, astrocytes and microglia become activated, alter 
morphology and release various cytokines, chemokines, reactive oxygen and nitrogen species as 
part of the innate inflammatory response  (Miller, Chen et al. 2011). These signals help recruit 
additional astrocytes and microglia to the injury site (Fawcett, Asher 1999). In the cases of 
severe injury, the astrocytic response can lead to the formation of a “glial scar", as we found 
along the ependymal lining in aged human tissue (Chapter 2, Shook et al, 2014).  While the 
purpose of forming a glial scar is often to repair or contain injury, it also has the potential to 
inhibit recovery after injury by impeding regrowth of neuronal processes and neo-vascularization 
(Kernie, Erwin et al. 2001). Furthermore, in the case of ependymal denudation, gliosis along the 
ventricular surface alters the CSF-ISF interface, which can have implications in clearance of 
toxic metabolites, fluid homeostasis and nutrient delivery.   In our model of rmTBI, areas of 
gliosis did not have the characteristics of a glial scar, but the gliotic response was heightened 
when the subsequent injury was delivered in rapid succession (Chapter 3, Acabchuk et al, 2016). 
Prior to testing drug treatment strategies aimed to reduce astroglial and microglial activation 
following brain injury, it is imperative to consider that brain injury causes damage but also 
stimulates repair; thus, it is essential to distinguish between a helpful and harmful responses 
when creating drug targets.  The astrocytic formations visualized by 3D imaging in Chapter 4 
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display the normal astrocytic state in two regions of the brain, the astrocyte-dense RMS and the 
hippocampus. These areas can then be used for comparison to injury or disease states and to 
evaluate therapeutic interventions. 
 
Consideration of altered mechanical properties 
In our studies, astrocytic gliosis played a prominent role in both changes to the ependymal lining 
in association to ventriculomegaly, and also as a focal response in periventricular structures 
following rmTBI. While astrocytic gliosis and microglial activation are associated with changes 
in chemical signaling, they also create changes in physical and mechanical properties of the 
brain. New imaging methods are being developed that may inform researchers and clinicians 
regarding how changes in structural integrity of specific brain regions may influence disease 
progression. Specifically, a new noninvasive method for measuring the mechanical properties of 
tissue called magnetic resonance elastography (MRE) works by generating vibrations that create 
minute internal tissue displacements to enable quantification of tissue stiffness  (Wang, Ganger 
et al. 2011). MRE is used to study fibrosis of the liver, and may also prove useful for assessing 
areas of gliosis in the brain, including the ependymal lining.   
 
Traumatic brain injury has been found to alter the elastic property of the brain under the area of 
impact.  In a controlled cortical impact (CCI) mouse model, MRE was used to demonstrate the 
biomechanical properties of the brain are altered following injury, causing a reduction in tissue 
stiffness (Boulet, Kelso et al. 2013). While CCI is a severe injury model that results in massive 
cell death, results from our rmTBI study demonstrating sustained increases in GFAP in the 
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lateral septum and hippocampus (Chapter 3, Acabchuk et al, 2016) suggest subtle changes in 
tissue structure may take place in deeper structures of the brain following repeated concussions.   
 
In addition to gliosis altering the mechanical properties of the brain, microglial activation may 
also lead to mechanical stress from increased pressure, which activates further cytokine 
secretion. New hypotheses are being developed that suggest the pathogeneses of Aβ and p-tau 
accumulation, as well as oncogene activation in cancer, are linked to increased pressure resulting 
from chronic inflammation  (Nogueira, da Veiga Moreira et al. 2015). Inflammation in the 
ventricular system/CSF pathway is associated with changes in intracranial pressure and 
subsequent development of hydrocephalus (Del Bigio, Di Curzio 2016). Future studies on aging, 
brain injury and neurodegenerative disease should take changes in structural and biomechanical 
forces into consideration.   
Ventriculomegaly 
CSF flow dynamics and the etiology of ventriculomegaly are more complex processes than 
previously thought.  Traditional assumptions associating ventricle expansion primarily with 
obstructive hydrocephalus or tissue atrophy can lead to an oversimplified or inaccurate 
perspective  (Rekate 2008). Recent identification of the glymphatic clearance system and brain 
lymphatic vessels discussed in Chapter 1, along with the results of our studies presented in 
Chapter 2 emphasize the importance of investigating changes in aging and disease from the 
perspective of the ventricular system.  Results presented in Chapter 2 show damage to the 
ependymal lining is associated with ventricle expansion in aged humans, and mouse models of 
ependymal gliosis can lead to ventriculomegaly. While ventriculomegaly is associated with 
several neurodegenerative diseases including CTE and AD, it is unknown whether this 
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association is coincidental or causally related  (Silverberg, Miller et al. 2010). Our studies 
assessing ventriculomegaly in an rmTBI mouse model did not reveal alterations in the 
ependymal lining or ventricle volume following repeated injury; however, this may also be due 
to a variety of factors (i.e., the disparity of brain volume to ventricle volume ratio between 
humans and mice, the location of the impact) (Chapter 3, Acabchuk et al, 2016). However, it 
remains possible that ependymal damage and associated ventriculomegaly contribute to the 
pathogenesis of CTE following rmTBI. Whether by subtle changes in intraventricular pressure, 
cilia damage, impaired CSF flow dynamics or other mechanisms, changes to the ventricular 
system can impair clearance of Aβ and p-tau thus contributing to neurodegenerative decline  
(Silverberg, Miller et al. 2010, Iliff, Wang et al. 2013, Iliff, Chen et al. 2014). Assessment of 
ependymal integrity should be a central consideration as researchers revisit previous assumptions 
of CSF flow dynamics in light of recent discoveries on brain lymphatic vessels, the glymphatic 
system, and effects of alterations in mechanical stiffness of tissue surrounding the lateral 
ventricles.   
 
Current rmTBI literature, limitations and future perspective 
Comparison of findings from various animal models of mild traumatic brain injury 
In order to place the findings of our rmTBI mouse model into context with other recent studies in 
a concise format, results from notable animal models of brain injury are listed in Table 1.  An 
important consideration in generating an animal model of repeated mild injury is to confirm that 
injury does not cause focal damage in the cortex below the site of injury.  Several studies listed 
in Table 1 found injury in the cortex.  In our studies, no microglial activation or GFAP 
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upregulation was found below the site of impact, which helps validate the mild nature of the 
model.  
Histological changes commonly noted in rmTBI studies using rodents include astrogliosis and 
microglial activation.  The majority of studies investigate these changes in the hippocampus and 
in the cortex, but often do not evaluate additional regions of the brain.  Our study found a 
localized histological reaction in the lateral septum, suggesting this region should also be 
considered as a region of interest in future rmTBI research. Structurally, cellular alterations 
generated in the septal area may contribute to cavum septum pellucidum in humans, a common 
feature noted in the pathological stages of CTE  (Kiernan, Montenigro et al. 2015).  Functionally, 
the lateral septum may be an important structure of interest in rmTBI research as it is part of the 
limbic system, and impairments in septal functioning can lead to emotional and memory 
impairments, two main features of the clinical development of CTE  (McKee, Stein et al. 2015). 
 
In order to further the field of rmTBI research, it is essential to be able to compare findings 
across studies.  Currently, this is a difficult endeavor, as each model uses different injury 
parameters and models are continually being modified, including the development of rodent 
helmets to minimize skull fractures and hemorrhaging  (Leung, Larimore et al. 2014, Petraglia, 
Plog et al. 2014).  So far, all clinical trials of drug interventions for mTBI and TBI have failed to 
demonstrate clinical efficacy (Marklund and Hillered 2011), but efforts continue to test 
therapeutic interventions in rmTBI models  (Zhang, Teng et al. 2015). Environmental factors 
including exposure to androgenic-anabolic steroids have been shown to exacerbate microglial 
activation and axonal injury in a rotational mouse model of repeated head injury  (Namjoshi, 
Cheng et al. 2016). Our studies contained a thorough baseline characterization of a large number 
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of antibodies across multiple brain regions using three post-injury time points and two different 
hit protocols, which may contribute to future testing of therapeutic interventions and various 
environmental exposures.   
 
Only a limited number of animal studies have demonstrated p-tau accumulation 
following rmTBI. Of the 15 studies listed in Table 1, only two studies reported increased p-tau 
following injury, with one study using a single TBI on AQP4-/- mice  (Iliff 2014), and the other 
using 42 hits on wild-type mice  (Petraglia, Plog et al. 2014).  Several other studies reported the 
absence of p-tau following rmTBI  (Mouzon, Bachmeier et al. 2014, Bolton, Saatman 2014), 
including a study that delivered 30 hits to 18m old triple transgenic Alzheimer’s (3xTg-AD) 
mice  (Winston, Noël et al. 2016).  There are a variety of factors that may contribute to the 
difficulty in replicating p-tau accumulation in rodent models, which may include differences in 
brain structure. P-tau accumulations first appear in the depths of the sulci in human CTE, which 
makes rodent models problematic as rodent brains are lissencephalic.  The lack of sulci and gyri 
means the rodent brain may not endure the same mechanical forces as the human brain following 
injury, which could impede initiation of p-tau accumulation  (Kim, Jeong et al. 2015).  Recent 
advances in understanding p-tau formation suggest p-tau is likely not to be found immediately 
following rmTBI. 
New discoveries highlight limitations of current rmTBI studies as well as potential future 
contributions 
The field of rmTBI research is changing rapidly, as illustrated by a recent discovery from 
researchers at the Program of Neuroscience at Harvard showing p-tau aggregates are preceded by 
decreases in the enzyme PIN1, which leads to a conformational change in tau preventing tau 
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dephosphorylation, known as cis-tau  (Kondo, Shahpasand et al. 2015). Antibodies labeling cis-
tau show cis-tau formation occurs rapidly following injury, and is upregulated following 
repeated injury. P-tau aggregates labeled by the AT8 antibody, on the other hand, likely do not 
occur until 6-12 months following injury in mice, and up to years later in humans according to 
this new research. Our rmTBI studies used AT8 to test for p-tau formation at time points that 
extended only until 6 weeks post-injury, which is likely why we had null findings. Given this 
new discovery, it is highly probable that our model would have demonstrated cis-tau 
accumulation following injury, and we would expect to find higher levels of cis-tau in the 
rmTBI-short protocol with hits delivered in rapid succession.  As our study was the first to 
implicate the lateral septum as a region of focal histological response in a mouse model of 
rmTBI, it would be interesting to investigate the regional distribution of cis-tau accumulation 
with our protocols in a future study. More promising research is currently underway testing 
antibodies that prevent cis-tau from forming, in the hopes of suppressing p-tau aggregates and 
associated neurological, cognitive and behavioral symptoms. These antibodies will be tested in a 
variety of rmTBI platforms, including weight drop models such as the one employed in our 
studies. Interestingly, preliminary data presented by Dr. Lu at the TBI Conference in Washington 
DC (May 2016) found that administering cis-tau antibody intravenously following rmTBI in 
rodents restores urinary incontinence, balance and memory, the triad of symptoms related to 
hydrocephalus, in addition to reducing gliosis, microglial activation and p-tau development.  
Future studies should investigate the link between increases in intraventricular pressure and p-tau 
progression.   
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Future perspective on rmTBI research 
Future study on concussions will likely unite a variety of techniques and protocols including 
animal studies, computer-generated modeling and human studies using advanced imaging, serum 
biomarkers and genetic screening. Data from animal studies will benefit from 3D imaging that 
will allow visualization and analysis of intact brain structures, and improved immunolabeling 
allowing greater differentiation of cellular subtypes in response to injury.  Together, these 
advancements will facilitate the development and evaluation of therapeutic interventions. New 
research advancements will identify vulnerable regions within the brain and link regional injury 
to clinical outcome.  Improved methods for detecting molecular and cellular alterations 
following concussion will also help to identify heightened risk from additional injury.  The 
results from our studies showing increased histological response following rapidly administered 
hits and focal damage in the lateral septum, hippocampus, and corpus callosum may contribute to 
future research testing antibodies preventing p-tau aggregation, the pathognomonic lesion of 
CTE.  By using a holistic view that includes the newly identified brain lymphatic vessels and 
CSF/ISF clearance routes, studies of repeated brain trauma may link regional histological 
changes, alterations in fluid barriers (i.e., ependymal lining, the interface of CSF/ISF), and/or 
changes in structural integrity to the etiology of long term rmTBI symptomology including CTE.     
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Table 1 Continued 
 
 
Table 1:  Summary of recently published histological findings using rodent models of rmTBI. 
 
 
 
 
(Luo, Nguyen et al. 2014, Mannix, Berglass et al. 2014, Aungst, Kabadi et al. 2014, Uryu, Laurer 
et al. 2002, Goddeyne, Nichols et al. 2015)  
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